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Abstract
A central question in many fields of scientific research is to determine how an outcome would be
affected by an action, or to measure the effect of an action (a.k.a treatment effect). In recent years, a
need for estimating the heterogeneous treatment effects conditioning on the different characteristics
of individuals has emerged from research fields such as personalized healthcare, social science,
and online marketing. To meet the need, researchers and practitioners from different communities
have developed algorithms by taking the treatment effect heterogeneity modeling approach and
the uplift modeling approach, respectively. In this paper, we provide a unified survey of these two
seemingly disconnected yet closely related approaches under the potential outcome framework. We
then provide a structured survey of existing methods by emphasizing on their inherent connections
with a set of unified notations to make comparisons of the different methods easy. We then review
the main applications of the surveyed methods in personalized marketing, personalized medicine,
and social studies. Finally, we summarize the existing software packages and present discussions
based on the use of methods on synthetic, semi-synthetic and real world data sets and provide some
general guidelines for choosing methods.
Keywords: Treatment Effect Heterogeneity Modeling, Uplift Modeling, Conditional Average
Treatment Effect.
1. Introduction
A fundamental question for scientific research is to determine whether changing an treatment would
affect the value of an outcome and to what extent. To answer this question, we need to estimate the
average effect of the treatment on the outcome known as the average treatment effect. For a treatment
such as a cancer therapy, oncologists want to estimate the average effect that the therapy would have
on the prognosis outcome, e.g., the expected survival time after treatment (Bellon, 2015). For a
treatment such as a job training program, social economists want to study the average effect of the
program on the employment prospective, e.g., whether the program reduces unemployment rates
(LaLonde, 1986). For a treatment such as an online advertisement, advertisers want to model the
average effect that the advertisement would have on the outcome, e.g., whether the advertisement
increases sales (Chickering et al., 2004).
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Fig. 4: The RFS curves of treated and untreated BRCA patients of each subgroups identified by SCT. First row shows the results on the
training data, second row shows the result on the test data. The unit of time is day.
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Fig. 5: The RFS curves of treated and untreated Glioma patients of each subgroup identified by SCT. First row shows the results on the
training data, second row shows the result the test data. The unit of time is day.
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Fig. 6: The Kaplan-Meier curve of the RFS for different subtypes
found by SS-Clust on both datasets. The unit of time is day.
disease subgroups. In order to utilize treatment information, genes
related to the RFS of treated and untreated patients are selected
separately. Then the union of two sets of selected genes is used
for the clustering procedure. The number of cluster k is determined
by the silhouette method (Rousseeuw, 1987). As shown in the
supplementary material, different k-values do not change the results.
The subgroups found by SS-Clust show different RFS curves
(Fig. 6). However, for each subgroup identified by SS-Clust,
the RFS curves between treated and untreated patients are not
significantly separated for either dataset (Fig. 7). These results
indicate that although SS-Clust is effective for finding subgroups
with different survival patterns, it is not effective for discovering
subgroups with heterogeneous treatment effects.
Proportional hazards (PH) model (Cox, 1972) is one of the
most widely used survival analysis methods. L1-regularized Cox
(Goeman, 2009) improves the high dimensional performance of PH
model by utilizing L1 regularization. In this comparison we use L1-
regularized Cox model (L1-Cox) with the following settings. The
regressors Xreg consist of treatment variable W , gene expression
levels X and the interaction term between the treatment and the
expression levelsW ·X, i.e.,Xreg = (W,X,W ·X). The shrinkage
parameter is selected by 5-fold cross validation. Once the regression
coefficients β are estimated, the patients are divided into four
subgroups according to the quartiles of value I = βXreg|W=1 −
βXreg|W=0, where I is the difference between treated prognostic
index (PI) and the untreated PI (Bovelstad et al., 2007).
For L1-Cox, the first and the last subgroups show different
treatment effects for both datasets (Fig. 8). Specifically, patients
in the first quartile show positive treatment effect, and those in the
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Figure 1: An example of heterogeneous treatment effects of radiotherapy on the survival curves of breast
cancer patients (Zhang et al., 2017). Patients in different subgroups are distinguished by their gene expression
profiles. The vertical axis is the survival probability of the patients, and the horizontal axis is the amount of
time after treatment. The p-value for the statistical significance of the difference between the two survival
curves are calculated using log-rank tests (Schoenfeld, 1981).
It is often not sufficient for scientists to only understand the average treatment effects of a given
population. For example, cancer patients may be more interested in the individual-level effects such
as “would this treatment be effective for a patient like me without the BRCA1 mutation?” since
many cancer treatments are known to be only effective for patients with certain gene expression
patterns (Bellon, 2015). From the perspective of the policy makers, it makes sense to only offer the
training program to those who are will benefit since the program’s effectiveness may depend on the
participants’ education backgrounds and caree histori s LaLonde (1986). For an online retailer, it is
also preferable to only target the persuadable customers in order to reduce the advertising cost, and
to avoid disturbing the “do-not-disturb” customers, i.e., those who do not wish to receive unsolicited
advertisements (Rzepakowski and Jaroszewicz, 2012b).
To meet the above needs, researchers need to inferenc the heterogeneous eff cts of the treatme t
for subjects defined by their different characteristics. For example, the heterogeneous effects of
radiotherapy treatment on cancer patients described by their gene expression profiles (Zhang et al.,
2017), the heterogeneous effects of a job training program on different participants defin d by their
demographical characteristics (Athey, 2017), and the heterogeneous effects of an advertisement
on the customers characterized by their purchase histories (Rzepakowski and Jarosz wicz, 2012b).
Motivated by the different application scenarios, researchers from two closely related yet surprisingly
isolated research communities, the treatment effect heterogeneity modeling and the uplift modeling
communities, have both contributed significantly to this problem. Many methods have be developed
by the treatment effect heterogeneity modeling community (Su et al., 2009; Hill, 2011; Su et al.,
2012; Imai and Ratkovic, 2013; Athey and Imbens, 2015; Louizos et al., 2017; Künzel et al., 2018;
Atan et al., 2018; Wager and Athey, 2018a,b; Zhang et al., 2017, 2018; Hass npour nd Greiner,
2018; Künzel et al., 2019), and the uplift modeling community (Hansotia and Rukstales, 2002;
Chickering et al., 2004; Diemert Eustache, Betlei Artem et al., 2018; Radcliffe, 2007; Rzepakowski
and Jaroszewicz, 2010; Guelman et al., 2012; Zaniewicz nd Jaroszewicz, 2013; Sołtys et al., 2015;
Guelman et al., 2015; Gutier ez and Gérardy, 2017; Yamane et al., 2018).
An exemplar application from the treatment effect heterogeneity modeling community is per-
sonalized medical treatment (Figure 1), where the goal is to study whether a medical treatment is
effective for patients defined by their characteristics based on for exam gene expression profiles. For
example, researchers developed a treatment effect heterogeneity modeling technique and studied
the effect of radiotherapy on the survival outcomes (Zhang et al., 2017) of breast cancer patients
measured by the Kaplan-Meier survival curves (Kaplan and Meier, 1958), and identified four patients
2
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Figure 2: An example of the incremental gain curves showing the extra sales of targeting different proportions
of the Customers with the two uplift modeling models using data obtained from Akanoo, an advertising
company for online retailers (Gubela et al., 2019). Customers are sorted in descending order of treatment
effects as ranked by the uplift models. The vertical axis shows the achieved number of incremental sales and
the horizontal axis shows the proportions of customers targeted. The dashed black line shows the uplifts of
random targeting.
subgroups with heterogeneous treatment effects where each subgroup is defined by its gene expres-
sion signatures. From the curves we can see that the treatment effects of radiotherapy are effective
for the patients in the fourth subgroup. However, for those in the first and the third subgroups, the
treatment effects are not significant. Furthermore, the treatment effects are negative for those in the
second group. Correctly estimating the treatment effect heterogeneity for patients is beneficial for
both patient welfare and the healthcare system.
The main focus of the uplift modeling community is targeted advertising, where the goal is to
predict whether a promotion would be effective for the customers defined by characteristics such as
their purchase histories and preferences (Figure 2). “Uplift” is a marketing term which refers to the
difference between the purchase behaviour (outcome) of a customer given the promotion (treatment)
and the outcome of the customer without the treatment. For example, in Figure 2 an e-commerce
company called Akanoo sent promotional emails to increase the sales of a smartphone (Gubela et al.,
2019), and built two uplift models. We can see that when targeting the same proportion of customers,
both uplift models achieve a sale increase than random targeting. Furthermore, Model 1 achieves
slightly more sales than Model 2 when 10% of the customers are targeted; however, more sales are
achieved by using Model 2 when more than 10% of the subjects are targeted.
Both the treatment effect heterogeneity modeling and the uplift modeling approaches share a com-
mon objective, which is to estimate the change in the outcome caused by the change of the treatment
for some given subjects, e.g., the changes in the survival outcomes caused by the radiotherapy and the
changes in the employment perspective caused by the the program in treatment effect heterogeneity
modeling, or the changes in the purchasing behaviour caused by the promotional email in uplift
modeling. However, a distinct difference between the algorithms from the two communities is that
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methods from the uplift modeling are implicitly designed for data from randomized experiments,
where the treatment is randomly assigned and the assignment mechanism is known to the experiment
designer; whereas those in the treatment effect heterogeneity modeling community explicitly specify
that the methods are designed for randomized experiments or observational data that satisfy certain
assumptions, e.g., the unconfoundedness assumption (Rubin, 1974).
Over the last few years, several surveys have been published in the uplift modeling community
(Gutierrez and Gérardy, 2017; Devriendt et al., 2018; Gubela et al., 2019). Particularly, Gutierrez and
Gérardy (Gutierrez and Gérardy, 2017) is the first to briefly discuss the link between uplift modeling
and treatment effect heterogeneity modeling. Unfortunately, to the best of our knowledge, none of
the literature explicitly discuss the necessary assumptions for unifying the methods from the two
communities. Furthermore, none of the existing work surveyed the connections between the methods
developed by the two communities using unified notations.
This article serves as a timely survey that connects the literature from the two seemingly different
yet closely related communities, namely the treatment effect heterogeneity modeling community and
uplift modeling community. The survey contributes to the literature in the following aspects. Firstly,
we explicitly present and discuss the fundamental assumptions that are required to unify the methods
proposed by the two communities under the potential outcome framework (Rubin, 1974). Secondly,
we survey and discuss the methods proposed by both communities using a unified set of notations.
The use of the unified notations allows us to provide clear discussions of the connections and the
distinctions between the methods proposed by the two communities. Thirdly, we present discussions
on the usability of the methods based on our evaluation on the available software packages developed
by both communities, and outline the challenges for both treatment effect heterogeneity modeling
and uplift modelling.
The structure of this survey is organized as follows: Section 2 is dedicated to unifying the
terminology, definitions for treatment effect heterogeneity modeling and uplift modeling. In Section
3 we provide a structured survey of existing methods proposed by both communities with unified
notations. We discuss the evaluation metrics of treatment effect estimation in Section 4. In Section 5,
we empirically survey the available software packages and source codes. Finally, we conclude the
survey in Section 6.
2. A Unified Definition for Treatment Effect Heterogeneity modeling and Uplift
modeling
In this section, we discuss and unify the definitions, assumptions and objectives for treatment effect
heterogeneity modeling and uplift modeling under the potential outcome framework (Rubin, 1974).
We denote the binary treatment variable as T ∈ {0, 1}, e.g. whether to treat a cancer patient
with radiotherapy or whether to offer a customer product discount. We use T = 0 to indicate no
treatment (control), and T = 1 to indicate treatment. Given the treatment T , every subject i has two
potential outcomes (Rubin, 1974) depending on whether the subject is exposed to the treatment or
not Let Yi(0) denote the potential outcome if the subject had received no treatment (control), and
Yi(1) denote the potential outcome if the subject had received the treatment (treated). The potential
outcomes can either be continuous, i.e., Y (0), Y (1) ∈ R or binary, i.e., Y (0), Y (1) ∈ {0, 1}. For
example, in cancer treatment, Yi(0) would corresponds to a continuous variable corresponding to the
number of years the patient would have survived without treatment, and Yi(1) would corresponds to
the number of years the patient would have survived with the treatment. In marketing, continuous
4
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potential outcomes could be used to denote the revenues under the treatment or control, or binary
potential outcomes can be used to denote whether the customer would purchase a product.
The Individual Treatment Effect (ITE) of the treatment T for the i-th subject τi on the outcome
is defined by the difference between the two potential outcomes of the subject i:
τi := Yi(1)− Yi(0). (1)
In an ideal world, knowing the individual treatment effect τi as defined in Equation 1 fulfils the
ultimate goal of both treatment effect heterogeneity modeling and the uplift modeling: they both
aim to predict the individual treatment effect. If the ITE is known, we know exactly whether an
individual should be prescribed a radiotherapy, or be sent a promotional email.
Unfortunately, only one of the two potential outcomes can be observed for any subject. For
example, if we have observed the potential outcome of a cancer patient who has received radiotherapy
treatment, we would not have known the patient’s potential outcome should he had received no
treatment (with control). The unobserved potential outcome is often referred as the counterfactual of
the observed outcome. We use Y to denote the observed outcome, which can be expressed using the
interaction between the treatment and the two potential outcomes as
Yi = TYi(1) + (1− T )Yi(0). (2)
At the data level, we can only observe the triplets (Xi, Ti, Yi), whereXi is the covariates that describe
the characteristics of the i-th subject. When the context is clear, we drop the subscript i for the
conciseness of the notations.
Since we never observe the two potential outcomes for any subject, the individual treatment effect
τi is not identifiable. With some adequate assumptions, it is possible to estimate the Conditional
Average Treatment Effect (CATE), defined as the average treatment effect conditioning on the set of
covariates that describes the subjects. Specifically, let X = x ∈ Rk be a k-dimensional covariate
vector describing the pre-treatment characteristics of the subjects, the conditional average treatment
effect, denoted as τ(x), is defined as
τ(x) := E[τ |X = x] = E[Y (1)− Y (0)|X = x]. (3)
Equation 3 is frequently used as the objective of treatment effect heterogeneity modeling methods
(Athey and Imbens, 2016; Zhang et al., 2017; Künzel et al., 2019). Although conditional average
treatment effect (CATE) is not exactly the same as the ITE, it has been shown that CATE is the best
estimator for the ITE in terms of the mean squared error (Künzel et al., 2019).
For uplift modeling techniques, they consider data with randomized treatment assignment, and
define their objective as the following.
Upl(x) = E(Y |T = 1, X = x)− E(Y |T = 0, X = x). (4)
We can see that the objective of treatment effect heterogeneity modeling (Equation 3) involves
conditional expectation of two potential outcomes, and could not be estimated directly from data in
current format. In contrast, the objective of uplift modeling (Equation 4) involves two conditional
expectations of the observed outcomes under the treatment and control and can be estimated in data
directly (but it has conditions for unbiased estimation). In the next section, we will discuss the
link between the treatment effect heterogeneity modeling and uplift modeling objectives and the
assumptions necessary for their estimations.
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2.1 Linking the Treatment Effect Heterogeneity and Uplift Objectives
We can re-arrange the objective of treatment effect heterogeneity modeling (Equation 3) using rules
of conditional probability and conditional expectations.
τ(x) =E[Y (1)− Y (0)|X = x]
=E[Y (1)|T = 1, X = x]P (T = 1) + E[Y (1)|T = 0, X = x]P (T = 0)
− E(Y (0)|T = 1, X = x)P (T = 1)− E[Y (0)|T = 0, X = x]P (T = 0)
=E[Y (1)|T = 1, X = x]− E[Y (0)|T = 0, X = x]︸ ︷︷ ︸
observed
+ P (T = 1){E[Y (0)|T = 0, X = x]︸ ︷︷ ︸
observed
−E[Y (0)|T = 1, X = x]︸ ︷︷ ︸
unobserved
}
+ P (T = 0){E[Y (1)|T = 0, X = x]︸ ︷︷ ︸
unobserved
−E[Y (1)|T = 1, X = x]︸ ︷︷ ︸
observed
}. (5)
The above equations decompose the objective into three components organized by three different
lines. For the two conditional expectations in the first line of Equation 5, observing the fact that the
potential outcome of treated (control) equals to the observed outcome when conditioning on T = 1
(T = 0), we have
E[Y (1)|T = 1, X = x]− E[Y (0)|T = 0, X = x] = E[Y |T = 1, X = x]− E[Y |T = 0, X = x].
(6)
It is worth noting that the expectations on the right hand side of Equation 6 is the same as the uplift
modeling objective as in Equation 4. Furthermore, both of the two conditional expectations only
involve observed outcomes without any counterfactuals. Their values can be unbiasedly estimated
with the overlap assumption and the stable unit treatment value assumption (STUVA).
Assumption 1 (Overlap) Any subject have a non-zero probability of receiving the treatment and the
control. In other words, all x in the support of X ,
0 < P (T = 1|x) < 1. (7)
The overlap assumption states that the probability of any subject with covariates x being treated is
bounded away from 0 and 1. This ensures that all types of individuals have been observed in both
treated and control groups. This is necessary, because if subjects with some covariates value x always
receive treatment (control) in the data, the expectations cannot be estimated.
Assumption 2 (SUTV) The Stable Unit Treatment Value (SUTV) assumption states that the individ-
uals do not interfere with each other. In other words, treatment applied to one subject does not affect
the outcome of other subjects.
Assumption 2 is usually satisfied in many health related applications. For example, it is reasonable to
assume that giving radiotherapy to one patient would not affect the life expectancy of other patients.
However, this assumption should be considered carefully in marketing applications where treatment
6
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to one subject may affect the treatment status of other subjects. For example, in online advertising
due to the wide existence of crowd-sourced coupon sharing websites, there is no guarantee that not
sending an email to an individual guarantees that the individual will be isolated from the promotion
because the individual may very likely obtain the same promotional information from other sources.
At this point, we have seen that the differences between the treatment effect heterogeneity
modeling objective and the uplift modeling objective lie in the last two components of Equation
5. These components are not estimable from the data since each of them involves a unobservable
potential outcome (counterfactual), e.g., E[Y (0)|T = 1, X = x] (the conditional average of potential
outcome Y (0) in the treatment group) and E[Y (1)|T = 0, X = x] (the conditional average potential
outcome of Y (1) in the control group). To overcome the counterfactual problem, methods in the
treatment effect heterogeneity modeling literature have introduced an important assumption which
assume that the potential outcomes are independent of the treatment assignments when conditioning
on the covariates, i.e., the unconfoundedness assumption:
Assumption 3 (Unconfoundedness) The distribution of treatment is independent of the potential
outcome when conditioning on the observed variables. Formally,
(Y (0), Y (1)) ⊥ T |X = x. (8)
The unconfoundedness assumption is also often referred as the strong ignorability assumption in
literature. Applying Assumption 3 to the second and third components of Equation 5, immediately
we can have the following results:
E[Y (0)|T = 0,x]− E[Y (0)|T = 1,x] = E[Y (0)|x]− E[Y (0)|x] = 0, (9)
E[Y (1)|T = 0,x]− E[Y (1)|T = 1,x] = E[Y (1)|x]− E[Y (1)|x] = 0. (10)
Therefore, given that the overlap, the STUVA, and the unconfoundedness assumptions are
satisfied, the objective of treatment effect heterogeneity can be written as:
τ(x) = E[Y |T = 1, X = x]− E[Y |T = 0, X = x]. (11)
When Assumptions 1, 2, 3 are satisfied, it is clear to see that the objective of treatment effect
heterogeneity modeling (Equation 11) and the objective of uplift modeling (Equation 4) are the
same. However, it is worth mentioning that the above three assumptions are not explicitly stated
or discussed in the majority of the uplift modeling literature. If the data does not satisfy these
assumptions, the estimated uplift will be biased since Equation 4 does not correspond to the true
effect of the action on the outcomes. In some of the uplift modeling works, it is implicitly assumed
that the data comes from randomized experiments or A/B tests (Gutierrez and Gérardy, 2017).
In data, a challenge lies in how to determine if Assumption 3, i.e., the unconfoundedness
assumption is satisfied as it is untestable from data. In other words, if the covariate set is correct for
exploring the treatment heterogeneities or building uplift models. This is an important related topic
but is out of the scope of our survey. A simple criterion for covariate selection is that the covariates x
contains all direct causes of the outcome Y and contain no effect variables of Y as shown in (Li et al.,
2020). For an in-depth discussion of the topic, we refer the readers to the works of VanderWeele and
Shpitser (2011); De Luna et al. (2011); Entner et al. (2013); Maathuis et al. (2015).
In this section, we have shown that given the overlap, the SUTV, and the unconfoundedness
assumptions, the objectives of uplift modeling and treatment effect heterogeneity modeling are
equivalent. In the remaining of this paper, we will use the term conditional average treatment effect
(CATE) for both treatment effect heterogeneity modeling and uplift modeling.
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3. Methods
In this section, holding that the data satisfies Assumptions 1, 2, and 3, we will provide an extensive
survey of the existing treatment effect heterogeneity modeling and uplift modeling algorithms using
a set of unified notations. We categorize the methods for treatment effect heterogeneity modeling
and uplift modeling into two major categories. The first category consists of extensions of existing
supervised modeling methods, and the second category consists of tailor designed methods for
treatment effect heterogeneity modeling and uplift modeling.
3.1 Extension of existing supervised learning methods
3.1.1 THE SINGLE MODEL APPROACH
Estimating the CATE in Equation 11 can be achieved by estimating conditional expectations (or
probabilities) from data. The problem then reduces to regression and classification. Specifically,
given a standard supervised model Y = µˆ(x), e.g., a regression algorithm for continuous outcomes
or a classification algorithm for binary outcomes. Given data triplets (Y,X, T ) which satisfies
Assumptions 1-3, the single model approach uses the concatenation of treatment and covariates
[T,x] as the features, Y as the target to build the estimator µˆ(x), and predicts the CATE for subjects
described by covariates x as
τˆ(x) = µˆ([T = 1,x])− µˆ([T = 0,x]). (12)
Lo (Lo, 2002) uses two estimators, a logistic regression model and a neural network with one
hidden layer, to estimate the uplift in a market experimental data set. In addition, Lo (Lo, 2002)
also proposes that standard supervised methods such as linear regression, regression tree, and spline
regression can also be used. Athey and Imbens (Athey and Imbens, 2015) implement the single
model method using regression tree for treatment effect heterogeneity modeling.
The single model approach is simple, easy to implement and has the flexibility of being able to
use any off-the-shelf supervised learning algorithm. However, a major drawback of this approach is
that one single model may not model both of the potential outcomes well and hence the estimation
may be biased. Another problem of the single model approach is that the estimator may not use the
treatment T in an model, such as a tree, and thus the CATE will be estimated as zero for all subjects.
3.1.2 THE TWO MODEL APPROACH
An improvement to the single model approach is to model the two potential outcomes using two
separate models, i.e., build two prediction models for the control and treated subjects respectively.
The two model approach makes use of existing classification or regression methods to build two
predictive models on the control and treated subjects separately and then uses the difference of the
two predictions as the estimated conditional average causal effect or uplift.
Specifically, given a standard supervised estimator Y = µˆ(x) for the functional relationship
between Y and x, given data triplets (Y,x, T ) which satisfies Assumptions 1-3, the two models
approach estimates the conditional average treatment effect as
τˆ(x) = E[Y |T = 1, X = x]− E[Y |T = 0, X = x]
= µˆ1(x)− µˆ0(x),
8
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where µˆ1 is trained using the outcome and covariates of the treated subjects, and µˆ0 is trained using
the outcome and covariates of the control subjects. It can be seen that the main difference between
the two model and the single model approaches is that the two model approach builds two separate
estimators for the treated and the control outcomes, whereas the single model approach builds one
estimators for both outcomes.
Any off-the-shelf estimator can be used to estimate µˆ(x). Popular choices include Linear
Regression as in (Hansotia and Rukstales, 2002; Cai et al., 2011), Regression Tree (Breiman et al.,
1984) as in the Two Tree method in (Athey and Imbens, 2015), Decision tree (Quinlan, 1993) as
in (Sołtys et al., 2015), Rule-Based Method as in (Nassif et al., 2012a, 2013), Gradient Boosting
Trees as in (Kane et al., 2014), and Bayesian Additive Regression Trees (BART) (Chipman et al.,
2010) as in (Hill, 2011).
The advantages of the two model approach lies in their simplicity and flexibility. Firstly, the
prediction models for the control and treated subjects can be built using a wide range of off-the-shelf
estimators. Secondly, the freedom of choice in the estimators provides flexibility for modeling
various treatment and outcome relationships. However, the disadvantages are that the two models are
built separately, and they do not utilize the information shared across the control and treated subjects
during estimation. Furthermore, they could not mitigate the impact of the disparity in covariate
distributions between the treated and control groups on the CATE estimation (Athey and Imbens,
2015).
3.1.3 X-LEARNER
Künzel et al. (2019) proposed an improvement to the two model approach called the X-Learner. A
motivation of the X-Learner approach is that the sample size in the treated group is usually very small,
and thus the model building of the two model approach can be difficult for the treated outcomes. To
address this problem, the authors proposed the X-Learner to crossover the information in the treated
and control subjects.
Specifically, the X-Learner approach consists of three steps. In the first step, two separate
estimators, µˆ1(x) and µˆ0(x), are built using the subjects from the treated group and control group
similar to the model building process in the two model approach. In the second step, the treatment
effects for the subjects in the treated group are imputed based on the differences between their treated
outcomes and the estimator µˆ0(x) built using the subjects from the control group, and the treatment
effects for the subjects in the control group are imputed based on the the differences between their
control outcomes and the estimator µˆ1(x) built using the subjects from the treated group. Specifically,
τˆ1i = Yi − µˆ0(xi), for subject i belonging to the treated group, and
τˆ0i = µˆ1(xi)− Yi, for subject i belonging to the control group,
where µˆ0 and µˆ1 are defined the same as in the two model approach.
Now we have two sets of imputed CATE estimations: τˆ1 corresponding to the CATE estimations
for the subjects in the treated group, and τˆ0 corresponding to the CATE estimations for the subjects in
the control group. Using these two sets of imputed CATE estimations, the X-Learner approach builds
two estimators τˆ1(x) and τˆ0(x) according to the covariates x along with τˆ1 and τˆ0, respectively. In
the final step, the CATE is estimated using a weighted average of the two estimators built in the
second step:
τˆ(x) = g(x)τˆ0(x) + (1− g(x))τˆ1(x), (13)
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where g(x) ∈ [0, 1] is a weight function. The authors of X-Learner suggest to define it as the
probability of a subject receiving the treatment, i.e., g(x) = P (T = 1|x). In practice, this probability
is referred to as the propensity score Rubin (1997) and is often estimated using logistic regression,
decision tree, neural network (Setoguchi et al., 2008) and boosting algorithms (McCaffrey et al.,
2004). For a comprehensive discussion of the propensity score, we refer readers to the work by
Austin (Austin, 2011).
An advantage of X-Learner is that it cross references the data in the treated and control groups,
and thus can perform better than the two model approach when the number of subjects in the treated
group is significant small than that of the control group; however, X-Learner requires the building of
four estimators and involves twice as many as the number of models built by the two model approach,
which may increase the risk of over-fitting and the difficulty for tuning parameters.
3.1.4 THE OUTCOME TRANSFORMATION APPROACH
The outcome transformation approach transforms the observed outcome Y to the transformed
outcome Y ∗ such that the CATE equals to the conditional expectation of the transformed outcome.
After the transformation, any off-the-shelf estimators can be directly applied to the dataset containing
the original covariates and the transformed outcomes for estimating CATE.
Specifically, an outcome transformation approach for the continuous outcome variable is used
in (Athey and Imbens, 2015) as the following,
Y ∗ =
Y
e(x)
· T − Y
(1− e(x)) · (1− T ), (14)
where Y ∗ is the transformed outcome, e(x) is the probability of a subject with covariate x receiving
the treatment, i.e., e(x) = P (T = 1|x). It is worth noting that the value of e(x) is unknown and
need to be estimated. In practice, e(x) is often estimated using logistic regression, decision tree,
neural network (Setoguchi et al., 2008) or boosting algorithms (McCaffrey et al., 2004). In literature,
e(x) is referred as propensity score (Rubin, 1997).
Using the above outcome transformation, it is straightforward to derive that the conditional
expectation of the transformed outcome equals to the CATE, i.e., E[Y ∗|X = x] = τ(x). Therefore,
any off-the-shelf regression algorithms can be used to estimate CATE by in a data set using Y ∗ as
the target and x as the covariates. In the treatment effect heterogeneity modeling community, an
instantiation of this approach using the regression tree is discussed by Athey and Imbens (2015).
For binary outcome, the following outcome transformation is proposed by Jaskowski and
Jaroszewicz (2012):
Y ∗ = Y T + (1− Y )(1− T ), (15)
where the transformed outcome Y ∗ thus corresponds to one of the following cases: Y ∗ = 1 if for a
subject we have T = 1 and Y = 1; Y ∗ = 1 if T = 0 and Y = 0; or Y ∗ = 0 if otherwise. Under
the assumption that e(x) = 0.5 for all x, i.e., the treatment is randomly assigned, Jaskowski and
Jaroszewicz (2012) proved that the CATE can be estimated as,
τ(x) = 2P (Y ∗i = 1|x)− 1. (16)
The outcome transformation in Equation 15 can be viewed as a special case of the transformation in
Equation 14 where the outcome Y is binary and e(x) = 0.5 for all x. Jaskowski and Jaroszewicz
(2012) then built a logistic regression model using the transformed outcomes. Weisberg and Pontes
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(2015) and Pechyony et al. (2013) also used the same transformation and logistic regression as the
base learner in their analysis.
The advantages of the outcome transformation approach is that after transformation the CATE
can be modelled directly. Furthermore, it provides the flexibility for choosing any existing off-the-
shelf supervised methods for CATE estimation. However, the outcome transformation approach
heavily relies on the accurate estimation of e(x). In Equation 14 the estimated e(x) appears in the
denominator, and thus small variations in the estimation of e(x) will lead to large variations in the
transformed outcomes.
3.1.5 DEEP LEARNING BASED METHODS
Recently, several deep learning based treatment effect heterogeneity modeling algorithms have been
proposed (Shalit et al.; Künzel et al., 2018; Louizos et al., 2017; Yao et al., 2018; Hassanpour and
Greiner, 2018). Here we introduce three types of deep learning based methods which extend the
single model approach, the two model approach and the X-Learner approach. Some other deep
learning algorithms that do not fall into the above three categories are discussed later in Section 3.2.3.
The advantages of deep learning methods are that they can use neural networks to model
complex non-linear relationships between the treatment and the covariates, and they can handle high
dimensional data large sample size thanks to the advantages of batch optimization. However, their
parameter turning is very difficult as in most data sets there are no ground truth treatment effects.
Deep-Treat Deep-Treat (Atan et al., 2018) is a deep learning based single model approach that
consists of two stages. The first stage of Deep-Treat takes the covariates and the treatment as
input, and utilizes a bias removing auto-encoder (Vincent et al., 2010) to learn a representation
Φ(x) of the original covariates x such that the treated and control groups are balanced. The
balancing of the learned representation Φ(x) is measured by the cross-entropy loss between the
marginal treatment distribution P (T ) and the conditional treatment distribution given the learned
representation P (T |Φ(x)). In other words, the learned representations are considered as balanced if
the cross entropy loss between the marginal distribution and the conditional distribution is minimized.
In the second stage, Deep-Treat uses the learned representation Φ(x), the treatment T and the
outcome Y as input, and train a single neural network to predict the outcome Y using the concatenated
features [T,Φ(x)]. The main advantage of Deep-Treat over the single model approach is that Deep-
Treat learns a balanced encoding for the control and treated subjects; however, it also inherits the
disadvantage of the single model approach.
Counterfactual regression CounterFactual Regression (CFR) (Johansson et al., 2016; Shalit et al.)
is a deep learning based methods that extends the two model approach. CFR estimates τ(x) by
learning two functions parametrized by two neural networks (similar to the two model approach)
from the data. Additionally, before learning the two functions, CFR performs representation learning
to minimize the discrepancy between the two distributions P (x|T = 0) and P (x|T = 1) measured
by either the Maximum Mean Discrepancy or the Wasserstein distance.
Several following works have been proposed to improve upon the CFR method. In particular,
CounterFactual Regression with Importance Sampling Weights (CFR-ISW) argues that the represen-
tation learned by CFR cannot completely eliminate the bias and adds a propensity network to alleviate
the problem (Hassanpour and Greiner, 2018). The Similarity preserved Individual Treatment Effect
estimation algorithm (SITE) (Yao et al., 2018) improves the learning of the common representation
by adding a Position-Dependent Deep Metric (PPDM) and a Middle-point Distance Minimization
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(MPDM) constraints. The main advantage of these methods over the two model approach is that
they learn a shared and balanced feature representation across the treated and control subjects which
could reduces the bias in the estimation; however, the involvement of training two neural network
models means that a larger dataset is required.
Y-Learner Following a similar motivation to the X-Learner approach, the Y-Learner (Künzel et al.,
2018) address the lack of information sharing between the treated and control groups of the two
model approach. Different from X-Learner which is consisted of three individual steps, the design of
the Y-Learner utilizes the iterative updating property of neural networks.
Specifically, the Y-Learner consists of three separate neural networks which are all iteratively
updated at each iteration of the back propagation: the first network is used for estimating the control
outcomes µˆ0(x), the second network is used for estimating the treated outcomes µˆ1(x), and third
network is designed for the CATE estimations τˆ(x). At each iteration, the Y-Learner updates the
parameters in the three networks using two different strategies depending on the treatment status
of the subject. Specifically, if Ti = 0, the Y-Learner first updates the neural network for estimating
µˆ0(x) according to Y , then it updates the neural network for estimating µˆ1(x) according to Y + τˆ(xi)
where τˆ(x) is estimated from the neural network from the last iteration, and finally it updates the
network for τˆ(x) using µˆ1(xi) − Y where µˆ1(x) is the updated network in the current iteration;
when Ti = 1, the Y-Learner first updates µˆ1(x) according to Y , then it updates µˆ0(x) according to
Y − τˆ(x), and finally it updates τˆ(x) using Y − µˆ0(x). After the optimizations, the estimated CATE
of a subject with covariates x is given by τˆ(x).
The improvement of Y-Learner to X-Learner is that the three neural networks in the Y-Learner
are iteratively optimized using back propagation, and thus the cross reference of the treated and
control subjects are promoted at each iteration. Recalling the procedure of the X-Learner where the
cross reference only happens once, we can see that the Y-Learner further encourages the information
sharing between the treated and control subjects. However, the use of neural network also means that
the Y-Learner does not have the flexibility of choosing the estimators.
3.2 Tailored Treatment Effect Heterogeneity modeling and Uplift modeling Algorithms
In this section, we survey methods that are specially designed for treatment effect heterogeneity
modeling or uplift modeling. We categorize the methods into four categories: the tree based methods
which build binary binary tree model using different splitting criteria, support vector machine (SVM)
based methods which reformulate uplift modeling problem within the SVM framework, generative
deep learning methods which utilize variational autoencoder or generative adversarial network to
generative the unobserved potential outcomes, and ensemble based methods that build upon the tree
based methods.
3.2.1 TREE BASED METHODS
Tree based methods build binary tree models for estimating the CATE. Both treatment effect het-
erogeneity modeling and uplift modeling communities have developed their tree-based methods
separately.
The model building procedure of tree based CATE estimation methods are similarly to existing
regression/decision trees (Breiman et al., 1984), in the sense that they all build tree models using
recursive partitioning. Starting from the root node, tree based methods recursively split the node into
two child nodes using a splitting criterion. The major difference between existing decision/regression
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trees and tree based CATE estimation algorithms lies in how they define the splitting criteria. In the
same fashion, the main difference among different tree based CATE estimation algorithms also lies
in their splitting criteria. Therefore, we will focus our discussion on the difference in the splitting
criteria of the surveyed tree based algorithms.
The main advantage of tree based methods is that their tree models are easily interpretable and
interpretability is very important for many CATE estimation applications. Furthermore, tree based
methods naturally provide the grouping of subjects with heterogeneous CATEs as defined by the
leaf nodes of the tree models. However, a major drawback of the tree based methods is that it is not
always clear what the “optimal” tree is, and differences between the best and second best tree found
by the same algorithm my differ significantly. In other words, tree based methods for treatment effect
estimation suffers from the problem of high variance.
Uplift Incremental Value Modeling Hansotia and Rukstales (2002) proposed the Uplift Incre-
mental Value Modeling (UpliftIVM) method which is one of earliest tree based method proposed
by the uplift modeling community. UpliftIVM searches for a splitting point that maximizes the
following splitting criterion:
CUpliftIVM := |τˆL − τˆR|, (17)
where τˆL and τˆR are the estimated conditional average treatment effect within the left and right child
node, respectively. In other words, the UpliftIVM algorithm aims to find the split that maximizes the
difference between the estimated CATE of the two child nodes.
Specifically, in the UpliftIVM algorithm, the within leaf CATE τˆL and τˆR are estimated as the
difference between the average treated outcome and the average control outcome using training data
within the node, i.e. τˆL =
∑nL
i=1 TiYi∑nL
i=1 Ti
−
∑nL
i=1(1−Ti)Yi∑nL
i=1(1−Ti)
and τˆR =
∑nR
i=1 TiYi∑nR
i=1 Ti
−
∑nR
i=1(1−Ti)Yi∑nR
i=1(1−Ti)
, where nL
and nR are defined as the numbers of subjects in left and right child nodes, respectively.
An advantage of the UpliftIVM algorithm is that it is simple and can achieve good performance
if the magnitude of treatment effect heterogeneity is large. However, it is also prone to outliers and
spurious treatment effect heterogeneities.
Squared t-statistics Tree Squared T-Statistic Tree (t-stats) (Su et al., 2009) is another early tree
based algorithm designed specifically for modeling treatment effect heterogeneity. It builds a tree
model by seeking the split with the largest value for the square of the t-statistic for testing the null
hypothesis that the average treatment effect is the same in the two potential leaves. The t-stats tree
maximizes the following splitting criterion:
Ctstats := (τˆL − τˆR)
2
σˆ2(1/n1L + 1/n0L + 1/n1R + 1/n0R)
, (18)
where σˆ2 =
∑
i∈{0,1}
∑
j∈{L,R}
nij−1
n−4 σ
2
ij where n = n0L +n0R +n1L +n1R. Here, n1L (n1R) and
n0L (n0R) denote the number of treated and control subjects in the left (right) child node, respectively;
σ21L (σ
2
1R) and σ
2
0L (σ
2
0R) are the sample variance of the treated and control subjects in the left (right)
child node, respectively.
For estimating the τˆL and τˆR within the child nodes, they are estimated as the difference
between the average outcomes of the treated and control groups, i.e., calculated as same as in Uplift
Incremental Value Modeling. It is clear to see that the numerator in the splitting criteria of t-stats and
UpliftIVM are close related, and their main difference is that the the former method (Equation 18)
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uses a pooled variance estimator (for estimating the common sample variances of various populations
with different means) to normalize the criterion.
Uplift Decision Tree Proposed by the uplift modeling community, the Uplift Decision Tree (Up-
liftDT) (Rzepakowski and Jaroszewicz, 2010) is a tree based methods designed for binary outcome
variables.
The motivation of UpliftDT is different from the previous three tree based methods. The previous
surveyed tree based methods aim to find the split that maximizes the difference between the estimated
conditional average treatment effect of the left and right child nodes. However, UpliftDT designs its
splitting criterion to maximize the estimated CATE within each child node. Specifically, UpliftDT
builds tree by maximizing the following splitting criterion:
CEu = nL
n
τˆ2L +
nR
n
τˆ2R, (19)
where the τˆL and τˆR are estimated as the difference between the average outcomes of the treated and
control groups, i.e., calculated similarly as previously surveyed tree based algorithms.
The above splitting criterion is referred as the Euclidean criterion by Rzepakowski and Jaroszewicz
(2010). To see this, note that for binary outcomes Y the treatment effect within a node can be written
as τˆ = P (Y |T = 1)− P (Y |T = 0), and thus τˆ2 can be viewed as the euclidean distance between
the treated and control subjects within the node.
Rzepakowski and Jaroszewicz (2010) also proposed two other splitting criteria based on using
KL-divergence and χ2-divergence of measuring the within-node difference of the treated and control
subjects. However, they argued that the Euclidean criterion is superior because it is more stable than
the other criteria and have the important property of being symmetric. It is worth noting that the χ2
splitting criterion has been investigated by others within the uplift modeling community. In the work
of Michel et al. (2017), a similar tree-based method is proposed utilizing the χ2-divergence.
A benefit of the splitting criteria of UpliftDT is that it can be extended to handle categorical
outcomes and multiple branch splitting of a decision tree. To see this, consider a p-way split, we
can rewrite the splitting criteria as CEu =∑pi=1 npn τˆ2p . It has also been extended to handle multiple
treatments by Rzepakowski and Jaroszewicz (2012a).
Balance-based and Significance-based Uplift Tree The The Balance-based Uplift Tree and
Significance-based Uplift Tree (Radcliffe and Surry, 2011) is another tree based method for bi-
nary outcomes proposed by the uplift modeling community.
The Ballance-based Uplift tree has two objectives: The first one is to maximize the uplift
difference in two splitting nodes. and the second one is to minimize of the difference in size between
the nodes. The following criterion is used to achieve the balanced objective.
CBL := |τˆL − τˆR|(1− |nL − nR
nL + nR
|α), (20)
where nL and nR are number of subjects in the left and right nodes respectively, 0 ≤ α ≤ 1 is a
hyper-parameter, and the τˆL and τˆR are estimated as the difference between the average outcomes of
the treated and control groups, i.e., calculated similarly as previously surveyed tree based algorithms.
The Significance-based Uplift Tree uses the significance of the interaction between the treatment
variable and a candidate splitting variable as a measure for the splitting quality. In each partition,
the data in current node is fitted with a linear model where each candidate split variable and the
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treatment form an internation term. The significance of the interaction is tested by a t- statistics, and
is indicated as the following.
CSIG := (n− 4)(τL − τR)
2
SSE · (1/n1L + 1/n0L + 1/n1R + 1/n0R) , (21)
where SSE =
∑
i∈{1,0}
∑
j∈{L,R} nijPij(Y = 1)(1−Pij(Y = 1)), and the τˆL and τˆR are estimated
as the difference between the average outcomes of the treated and control groups, i.e., calculated
similarly as previously surveyed tree based algorithms.
The splitting criterion of Balance-based Uplift Tree is closely related to the criterion of the
UpliftIVM method. Furthermore, for the Significance-based Uplift Tree, it can be seen that the SSE
of Equation 21 is the weighted sum of the population variances. Contrasting the splitting criterion
of Significance-based Uplift Tree (Equation 21) with the splitting criterion of t-stats (Equation 18),
the two criteria are equivalent except that t-stats uses the sample variances instead of population
variances in the denominator.
Causal Inference Tree The Causal Inference Tree (CIT) (Su et al., 2012) is a tree-based method
for treatment effect heterogeneity modeling, proposed by the same author as the t-stats tree. CIT
assumes that the potential outcomes Y (0) and Y (1) come from two Gaussian distributions with the
same variance. In other words, Y (T ) ∼ N (Tµ1 + (1− T )µ0, σ2) where σ2 is the variance, µ1 and
µ0 are the means of the treated and control outcomes, respectively. Furthermore, CIT assumes that
the treatment follows a Bernoulli distribution T ∼ Bernoulli(pi). Using these assumptions, CIT then
proposes to find the split that maximizes the log-likelihood within the nodes defined as follows:
CCIT :=− nL
2
· ln(nLSSEL)− nR
2
· ln(nRSSER)
+ n1L lnn1L + n0L lnn0L + n1R lnn1R + n0R lnn0R, (22)
where the SSEL and SSER are the sum of squared errors for the left and right child nodes. For
instance, SSER is defined as SSER =
N1R∑
i=1
(Yi− Yˆ1)2 +
N0R∑
i=1
(Yi− Yˆ0)2 where Yˆ1 =
NR∑
i=1
Yi ·Ti/
NR∑
i=1
Ti
and Yˆ0 =
NR∑
i=1
Yi · (1 − Ti)/
NR∑
i=1
(1 − Ti) are the means of the treated and the control outcomes
within the right child node, and SSEL is defined similarly. The authors showed that CIT consistently
performs better than the t-stats tree.
Causal Tree Athey and Imbens (2016) have proposed the Causal Tree (CT) algorithm, a recent
tree-based algorithm designed specifically for the estimation of CATE. A main difference between
CT and the previously mentioned tree based methods is that the authors propose CT to be an “honest”
approach where the term indicates that CT divides the training data (of size n = ns + ne) into two
parts, the splitting set (of size ns) and the estimation set of (of size ne). The subjects in the splitting
set are used for determining the split and the subjects in the estimation set are used for estimating the
CATE within the node. The splitting criterion of CT can be represented as the following:
CCT := (nL
n
τˆ2L +
nR
n
τˆ2R)− (
1
n
+
1
ne
)(
S21L
p
+
S20L
1− p +
S21R
p
+
S21R
1− p), (23)
where S1L, S0L, S1R, S0R denote sample variances of treated and control subjects in left and right
nodes, respectively. ( 1n +
1
ne ) is the weight to penalize small sized leafs, and p is the marginal
treatment probability in data sample including training data set.
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Different from other tree methods, in CT, τ in all nodes are estimated using inverse propensity
score weighting method (Rosenbaum and Rubin, 1983) with the subjects within the node as the
following:
τˆ(x) =
∑
xi∈N
Ti·Yi
e(xi)∑
xi∈N
Ti
e(xi)
−
∑
xi∈N
(1−Ti)·Yi
(1−e(xi))∑
xi∈N
1−Ti
(1−e(xi))
, (24)
where N is a node, and e(x) = P (T = 1|x) denotes the propensity score for subject x.
Athey and Imbens (2016) have also discussed an “adaptive” CT tree where the splitting criterion
does not have the variance part (the second term) and the algorithm does not divide the data into
two sets. Recall the splitting criterion of UpliftDT (Equation 19), it is clear to see that the splitting
criteria of the adaptive version of CT and UpliftDT are equivalent. In their evaluation, the honest CT
tree performs consistently better than the adaptive CT tree. However, a drawback of the honest CT is
that it effectively only utilizes half of the dataset because it requires dividing the subjects into the
splitting and the estimation sets.
Bayesian Score Tree The Bayesian Score Tree (Chickering and Heckerman, 2000) is an early
method designed for targeted advertising and is different from the previously surveyed methods. It
does not directly maximize the uplift difference in each split. Instead, it models the uplift as a new
split by the treatment variable on a child node. Each child node is forced to be split by the treatment
variable if its path does not contain the treatment variable. A child node is removed if the overall
tree quality score does not increase when it is split by the treatment variable. The uplift is calculated
by difference between the outcome probabilities in the left and right child nodes. A Bayesian score,
such as the one used by Buntine (1993), is employed to calculate the score of the candidate trees.
3.2.2 SUPPORT VECTOR MACHINE BASED UPLIFTING MODELING METHODS
In this section, we discuss the methods that utilize support vector machine (SVM) (Cortes and Vapnik,
1995) for CATE estimation proposed in the uplift modeling community. The main benefit of these
methods is that by reformulating the uplift modeling problem within the SVM framework, they enjoy
the benefit of SVM which has been proven to be effective in many supervised learning applications.
However, a problem of these methods is that none of them have implementation available online and
the implementation could be difficult for potential users.
L1 and Lp Uplift SVMs Zaniewicz and Jaroszewicz have presented two methods that utilize
SVM for uplift modelling, the L1-Uplift Support Vector Machine (L1-USVM) and the Lp Uplift
Support Vector Machine (Lp-USVM) (Zaniewicz and Jaroszewicz, 2013, 2017). They recast the
uplift modeling problem as a three class classification problem. Specifically, the the two USVM
methods aim to predict whether the treatment has positive treatment effect, no treatment effect,
or negative treatment effect. USVMs achieve this goal by using two parallel hyperplanes as the
following:
H1 : 〈w,x〉 − b1 = 0, H2 : 〈w,x〉 − b2 = 0, (25)
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where b1, b2 ∈ R are the intercepts, x is the coefficients of the decision boundary. The predicted
treatment effect is then specified as:
τˆ(x) =

+1 if 〈w,x〉 > b1 and 〈w,x〉 > b2,
0 if 〈w,x〉 ≤ b1 and 〈w,x〉 > b2,
−1 if〈w,x〉 ≤ b1 and 〈w,x〉 ≤ b2.
(26)
The first L1-USVM method utilizes the L1-norm as the regularization forw, but it is sensitive to the
parameter setting because of discontinuity problem with L1-norm. A Lp-Support Vector Machines
for uplift modeling has been proposed by utilizing Lp-norm in the optimization to replace L1-norm
(Zaniewicz and Jaroszewicz, 2017). Lp-USVM not only resolves the discontinuity problem but
also improves the convergence and efficiency and provides more stable results. However, it also
introduces an additional hyper-parameter p that needs to be tuned.
The above two methods are designed for data from randomized controlled trials. The authors also
extended this line of work to observational data by adding one more regularization term (Jaroszewicz
and Zaniewicz, 2015). However, adding the additional regularization term makes the objective
function difficult to optimise because the derivatives of the new objective function may not exist.
Lift curve SVMs Another contribution from the uplift modeling community is the Support Vector
Machines for Differential Prediction (SVMUpl) (Kuusisto et al., 2014). In the SVMUpl method, the
authors proposed to directly find the decision boundary that maximizes the Area Under the Uplift
curve (AUU). The uplift curve is an evaluation metric used by the uplift modeling community for
comparing the performances of the uplift models. We will give the precise definition of the uplift
curve (Equation 30) when introducing the evaluation metrics (Section 5.3). Intuitively, the idea of
SVMupl is similar to the SVM methods for supervised learning that maximizes the area under the
ROC rurve (AUC), e.g., SVMperf (Joachims, 2005); however, instead of maximizing the AUC for
supervised learning, SVMupl maximizes AUU for uplift modeling.
The authors have showed that maximizing the AUU is equivalent to maximizing a weighted
difference between the AUC for the treated group and the AUC for the control group. Specifically,
max(AUU) ≡ max(AUCT=1 − λAUCT=0), (27)
where λ =
n∑
i=1
Yi(1−Ti)
n∑
i=1
(1−Yi)(1−Ti)
n∑
i=1
Ti
n∑
i=1
YiTi
n∑
i=1
(1−Yi)Ti
n∑
i=1
(1−Ti)
. Furthermore, the difference in Equation 27 is equivalent
to the sum of the AUC for the treated group and the AUC of the control group by flipping the control
group outcomes:
max(AUU) = max(AUCT=1 − λ(1−AUC−T=0)) = max(AUCT=1 + λAUC−T=0)
where AUC−T=0 indicates the AUC of the control group with flipped outcome labels.
By showing maximizing the AUU is equivalent to maximizing the sum of two AUCs, the authors
then solve the SVMUpl optimization problem by utilizing the SVMperf algorithm (Joachims, 2005)
which is designed to directly optimize the AUC.
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3.2.3 DEEP LEARNING BASED METHODS
Recently, several generative learning methods for treatment effect heterogeneity modeling has been
proposed. We survey them separately from the previous discussed deep learning methods since the
generative approach of these methods do not falls into the single model, two model or X-Learner
approaches discussed previously.
Causal Effect Variational Autoencoder Causal Effect Variational AutoEncoder (CEVAE) is a
Variational AutoEncoder (VAE) based treatment effect heterogeneity modeling approach. This
method uses VAE to learn a latent confounding set z from the observed covariates x and then use z
to estimate CATE. The VAE (Kingma and Welling, 2014) is a new type of autoencoder based on
variational inference which is able to conduct approximately inferencing on the intractable posterior
of the latent variables. CEVAE assumes that the observed covariates x is conditional independent of
both the treatment assignment and the outcome once the latent confounders z have been observed.
Then it uses VAE to inference the posterior of the latents p(z |x). CEVAE then estimate the CATE as
τˆ(x) =
∫
z
p(y|z, T = 1)p(z |x)dz −
∫
z
p(y|z, T = 0)p(z |x)dz (28)
The advantage of CEVAE is that it is capable of inferring unobserved confounders that are
difficult to measure from observed proxy variables, e.g., the income of a patient is often not available
from electronic medical records but they can be inferred using the postcode, occupation as proxies.
However, the drawback of CEVAE is that there is no theoretical guarantee on whether the inferred
latent posterior p(z |x) will converge to the true posterior because CEVAE relies on variational
approximations. Another drawback of CEVAE lies in its assumption. It assumes that the latent
factors z completely separates x from T and Y . This is a strong assumption and may not be satisfied
by the data.
A recently proposed improvement of the CEVAE method is the Treatment Effect by Disentangled
Variational Autoencoder (TEDVAE) method (Zhang et al., 2020). Instead of learning a single latent
factors z from x as in CEVAE, TEDVAE learns three separate sets of factors: instrumental factors
z t, confounding factors zc, and risk factors zy. The instrumental factors affect only the treatment,
the confounding factors affect both the treatment and the outcome, and the risk affect only the
outcome. TEDVAE has improves upon CEVAE on two aspects, firstly by categorizing the latent
factors into three sets, TEDVAE avoids the additional assumption of CEVAE; secondly, the need
for separating the instrumental from confounding and adjustment factors arises from the avoid
the problem that including factors unrelated to the outcome increases the bias and variance in the
treatment effect estimation (Abadie and Imbens, 2006). However, TEDVAE still suffers from the
approximate inference problem as in CEVAE.
Generative Adversarial Network for Individualized Treatment Effects Generative Adversarial
Networks for Individualized Treatment Effects (GANITE) (Yoon et al., 2018) utilizes Generative
Adversarial Network (GAN) to model treatment effect heterogeneity. GANITE consists of two
components, a counterfactual block that generates the counterfactual outcome Y cf with input
(x, T, Y ), and a so-called ITE block that generates the conditional average treatment effect τˆ(x) for
subjects with covariates x.
Specifically, the counterfactual block contains a generator G paired with a discriminator DG.
G takes input (x, T, Y ) and generates a counterfactual Y cf for the treatment 1 − T , while DG
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takes (x, Y, Y cf ) as input and outputs whether the outcome is generated by G. During training,
G is trained to maximize the probability of DG incorrectly identifying whether Y cf is factual or
counterfactual, whileDG is trained to maximize the probability of correctly distinguishing Y cf from
Y . After training the counterfactual block is completed, the counterfactual outcome Y cf generated
by G along with (x, T, Y ) are fed into the ITE block which consists of a generator I paired with
an discriminator DI. The generator I takes the covariates x as input and generates the potential
outcomes Y and Y cf , and the discriminator DI aims to discriminate whether these outcomes are
generated by I or are the inputs from the counterfactual block (generated byG). After training, only
the generator I in the ITE block is used for predicting the CATE of new subjects.
3.2.4 ENSEMBLE BASED METHODS
Ensembles based CATE estimation methods are proposed to address the high variance problem of
tree based methods. Most of the surveyed ensemble methods use tree based method as base learners.
Generally speaking, ensemble based CATE estimation methods performs better than the single tree
model built by tree based methods. However, ensemble based methods lose the interpretability of
tree based methods, and have higher time complexity than tree based methods.
Uplift Bagging Bagging (Breiman, 1996) is a simple and popular ensemble method in supervised
learning. A set of bootstrap training data sets are randomly sampled from the original training data
set with replacement. A bootstrap training data set has the same size as the original training data
set. A model is built on each bootstrap training data set. The final prediction for a test subject is the
average of predicted uplifts of all models on the example.
For CATE estimation, Radcliffe and Surry (2011) mentioned they had used Bagging in real
world applications in their report; however, no experiment results were provided. Sołtys et al. (2015)
have implemented and compared two Bagging methods. The base learners used are Uplift Decision
Tree (using Euclidean distance (Rzepakowski and Jaroszewicz, 2010) and Two Model Decision Tree
(using C4.5 (Quinlan, 1993) as discussed in Section 3.1.2). Based on their evaluations (Sołtys et al.,
2015), the Uplift Bagging methods perform significantly better than the uplift decision trees, and are
competitive to Uplift Random Forest method to be discussed below.
Uplift Random Forest Uplift Random Forest (UpliftRF) (Guelman et al., 2012, 2015) is an uplift
ensemble model based on the idea of Random Forest (Breiman, 2001). Firstly, a set of bootstrap
training data sets are randomly sampled from the original training data set with replacement. Secondly,
each bootstrap training data set is projected to a fixed number of k randomly selected covariate space.
Thirdly, a Uplift Decision Tree (Rzepakowski and Jaroszewicz, 2010) is built on every training data
set from the above two steps. Fourthly, the set of uplift trees are used to predict the uplift for a new
subject by using the average of predicted uplifts of all trees.
Sołtys et al. (2015) have also implemented another random forest like algorithm called Double
Uplift Random Forests (DURF). DURF is a bagged ensemble of Two Model based on randomized
trees from Weka (Hall et al., 2009). In their evaluation, both UpliftRF (using Euclidean distance)
and DURF perform better than the two model decision trees, but are not significantly different with
Bagged Uplift Decision Tree (using Euclidean distance) (Rzepakowski and Jaroszewicz, 2010) and
Bagged Two Model Decision Tree (using C4.5 (Quinlan, 1993)).
Causal Conditional Inference Forest Guelman et al. (2014) proposed the Causal Conditional
Inference Forest (UpliftCCIF) as an ensemble uplift modeling method. It is based on tree models
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and uses a similar strategy as UpliftRF to construct the ensemble of trees, i.e., by random sampling
the training subjects and covariates with replacement. The major difference between UpliftCCIF and
UpliftRF lies in the tree splitting procedure. Whether to split the node in a base learner tree model of
UpliftCCIF is determined by testing the null hypothesis of no interaction between the treatment T
and any of the covariates in x. Specifically, the null hypothesis is formulated as H0 = ∩kj=1Hj0 with
Hj0 : E[Y ∗|xj ] = E[Y ∗] where Y ∗ is the transformed outcome as discussed in Section 3.1.4 and xj
is a covariate in x. The authors use Bonferroni-adjusted p-values for handling the multiplicity in the
statistical tests. If the null hypothesis is rejected, the splitting covariate is selected as the one with the
smallest p-value. After the trees have been built, the uplift of a subject is estimated as the average of
the uplifts predicted by the individual trees.
Causal Forests Wager and Athey (2018b) proposed the Causal Forests (CF), a random forest
like algorithm for treatment effect heterogeneity modeling. Causal Forest uses the Causal Tree
(CT) algorithm (as discussed in Section 3.2.1) as its base learner, and constructs the forest from an
ensemble of k causal trees where each tree provides a CATE estimation τˆb(x) for a subject. The forest
then uses the average of the predicted CATE from k trees as its prediction, i.e., τˆ(x) = 1k
∑k
b=1 τˆb(x).
An important advantage of Causal Forest over the other surveyed ensemble methods is that the
authors have proved that the estimation of Causal Forest is asymptotically Gaussian and unbiased for
the true conditional average treatment effect τ(x). In other words, (τˆ(x)− τ(x))/√V ar(τ(x))→
N (0, 1). Furthermore, the authors also provided a way for accurately estimating the asymptotic
variances.
Another advantage of Causal Forest is that it is a general framework in the sense that its theoretical
properties are valid as long as the trees used as base learners are “honest”, i.e., the outcome of any
sample is not used for both selecting the split and estimating the within-leaf CATE τˆ (as discussed
in the Causal Tree method in Section 3.2.1). Based on this property, the authors also proposed a
Causal Forest instantiated using the so-called propensity tree, which completely ignores the outcome
Y when choosing the splits and builds the tree using the Gini criterion (Breiman et al., 1984) of the
treatment T .
4. Applications
In this section, we discuss the main applications inpersonalized medical treatment and social eco-
nomics applications from the treatment effect heterogeneity modeling community, and targeted
advertisement applications from the uplift modeling community. While applications in the uplift
modeling community almost solely rely on data from randomized experiments, those in the treatment
effect heterogeneity community often have to resort to observational data since the ethical and cost
concerns often prohibit controlled trials in medical and social studies.
4.1 Applications in marketing
Driven by the companies’ need of increasing sale while minimizing advertisement costs, targeted
advertising has long been the major focus of the uplift modeling community. Most of the work in
this area are based on real-world datasets obtained by randomized experiments, and some of the
results have been utilized by advertising companies according to the literature. The results in these
applications confirm that using uplift modeling to target customers is more effective than random
targeting or using standard supervised learning.
20
SURVEY OF TREATMENT EFFECT HETEROGENEITY AND UPLIFT MODELING
Chickering and Heckerman (2000) applied the Bayesian Score Tree for method (discussed in
Section 3.2.1) to an MSN advertising experiment data set. Registrants of Windows 95 were randomly
divided into treatment and control groups. Advertisement mails for MSN subscription were sent to
the treatment group, but nothing were sent out to the control group. The outcome was MSN sign-up
within a given time period. 110, 000 subjects were used in the experiment, where the treatment
subjects account for 90% of the total. 70% of the data were used for training models and the other
30% of were used for evaluation. The average expected uplift in profit was used as the evaluation
criterion. Their results showed that the uplift model achieved more revenue when compared to the
mail-to-all strategy.
Hansotia and Rukstales (2002) applied the uplift incremental value modeling (IVM) algorithms
to (discussed in Section 3.2.1) analyze customer responses to a $10 off $100 purchase promotion.
The data was obtained from a holiday promotion of a major national retailer in the United States.
Promotional mails (treatment) were randomly sent to 50% out of the total 282,277 customers. They
compared a two model approach using logistic regression with the IVM. The evaluation criterion is
the uplift in the 50% reserved evaluation dataset (and the other 50% is used for building models).
Their results showed that IVM performed better than the two model approach when targeting the top
10% of customers, while their overall performances are similar.
Radcliffe (2007) discussed three real-world applications of uplift modeling in marketing: Deep-
Selling where the goal is to use a promotion to increase the frequency or size of customer transactions,
Customer Retention which aims to mitigate customer attrition, and Cross-Selling which is used to
sell new products to existing customers. Deep-Selling includes 100,000 subjects and the treatment
and control groups are split by 50:50. The sample sizes in two other examples are not reported.
They used the Balance uplift tree (Radcliffe and Surry, 2011) (discussed in Section 3.2.1). In deep-
selling, the authors showed that the uplift modeling approach was better at increasing revenue when
compared to standard supervised methods. In customer retention, they considered a problem where
a mobile service provider was experiencing an annual churn rate of 9%. Originally, the company
targeted its entire customer base with a retention offer and the churn increases by 1%. Using uplift
modeling, they were able to achieve 7.8% of customer churn when targeting 30% of customers with
the highest predicted uplifts, over 13% fewer customer churn. Using an estimated average revenue
per user (ARPU) of $400/year, the increase of revenue by uplift modeling is around $8.8 million. In
cross-selling, they tackled a banking problem where banks want to sell new banking products to their
existing customer bases. They have shown that by using uplift modeling, they can achieve between
80% and 110% of sale increase while reducing the volume of mailing offers by 30% to 80% when
comparing to using standard supervised learning.
Guelman et al. (2012) applied several uplift modeling methods to a real-world customer retention
dataset of a Canadian insurance company. A randomized experiment was conducted with a treatment
group of 8249 subjects and a control group of 3719 subjects whose policies were due for renewal.
The customers in the treatment group received a letter to explain the insurance premium increased,
and also received a phone call from an insurance advisor. The customers in the control group
received no retention effort. Four methods have been applied to the data set including Uplift Random
Forest (discussed in Section 3.2.4), the two model approach with logistic regression, the single model
approach using logistic regression with interaction terms between the treatment and all covariates (Lo,
2002), and Uplift Decision Tree (discussed in Section 3.2.1) (Rzepakowski and Jaroszewicz, 2010).
Based on the uplift curves obtained from 10-fold cross validation, all methods performed better
than the baseline retention rate by randomly targeting. Furthermore, the Uplift Random Forest
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performs better than the others especially in top ranked customer subgroups, but did not dominate
other methods in the other customer subgroups.
An open-access uplift modeling dataset is the Hillstrom’s MineThatData Email Analytics chal-
lenge (Hillstrom, 2008), which contains 64,000 samples collected from a randomized experiment of
an email advertisement campaign. The customers were evenly distributed in two treatment groups
and a control group, where the first treatment was sending a “Men’s Advertisement Email” and
the second treatment was sending a “Women’s Advertisement Email”. The control group received
no email. The outcome variables were the visit and conversion status of the customers. Radcliffe
(Radcliffe, 2008) has conducted analysis using the Hillstrom dataset, in which it was shown that the
“Men’s Email” was more effective than the “Women’s Email” and the best customer subgroup to
target was those who have visited the store using both phone and web browser, and have spent more
than $160. It has also been identified that there is some customers who were negatively affected by
the “Women’s Email”, and also customers who received no effect from neither of the treatments.
4.2 Applications in social science
Social science is one focus of the treatment effect heterogeneity modeling community. Although
some of the literature in this area also used randomized experiments data as those in the uplift
modeling community, many of the social science applications need to deal with observational data as
controlled experiments are often not feasible due to ethical and cost concerns.
Imai and Ratkovic (2013) analysed the get-out-the-vote (GOTV) (Gerber and Green, 2000)
randomized experiment where 69 different voting mobilization methods, including canvassing (a in-
person direct contact to encourage voting), phone call and mailing were randomly given to registered
voters in New Haven, Connecticut during the 1998 U.S. presidential election. The goal of their
analysis is to select the best voting mobilization strategy for individuals. To avoid the interference
between voters within the same household (which violates the SUTV assumption), they focus on the
subset of 14,774 voters in single voter households, of which 5269 voters belongs to the control group.
They used a single model approach (as discussed in Section 3.1.1) with a modified SVM algorithm
(Cortes and Vapnik, 1995) as the base learner. Specifically, they used two separate L1-regularization
terms for covariates that only affects the outcome, and for covariates that interact with both the
outcome and the treatment (the type of covariates are manually specified by the author for the dataset).
Their analysis shows that canvassing is the most effective treatment. When canvassing is used, any
additional treatment such as phone calling and mailing in combination with canvassing will reduce
the effectiveness of canvassing. In addition, when canvassing is absent, the most effective treatment is
contacting by mails with a civic duty appeal while any other treatment was found to be less effective
or have negative effect on the turnout.
Imai and Ratkovic (2013) also analysed the dataset from the national supported work (NSW)
program (LaLonde, 1986; Dehejia and Wahba, 1999) where the goal is to study whether a job training
program will increase the income of workers. The data contains 297 and 425 workers randomly
assigned to the treatment and control groups, and 1978 panel study of income dynamics workers
(PSID) from low-income subjects. In other words, the dataset consists of two components where the
first component is obtained from a randomized controlled trial (the NSW sample), and the second
component is obtained from an observational study (the PSID sample). The method used is the
same as the one described in the GOTV application. They built their model on the randomized
NSW samples and applied their to the PSID samples. Their analysis shows that overall the training
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program is beneficial to the participants. However, it benefited educated Hispanics and low income
non-Hispanics the most, but did not help employed white workers with high school degrees at all.
Künzel et al. (2019) analysed a field experiment for the effect of canvassing (a in-person direct
contact by conversation) on reducing transphobia (prejudice against transsexual or transgender
people). The dataset was originally used by Broockman and Kalla (2016) where it has been
shown that brief but high-quality canvassing can significantly reduce prejudice against transgender
individuals for at least the duration of 3 months. The dataset consists of three groups, a treatment
group of 913 individuals who are canvassed on the topic of reducing transphobia, a placebo group of
912 individuals who are canvassed by an irrelevant conversation, i.e. about recycling, and a control
group of 68,278 individuals who have not been canvassed at all. The outcomes of interest were the
results of an online survey that measure the subjects’ attitude towards transphobia at 3 days after
the treatment. Using covariates such as religion, ideology and demographics, the authors applied
the single model approach, the two model approach and the X-Learner (as discussed in Section
3.1) using Random Forest as base learners. The results showed that the treatment effects estimated
by the single model approach are mostly 0 or almost 0, despite the fact that the average effect of
the treatment is 0.22 (Broockman and Kalla, 2016). The two model approach and the X-Learner
produced similar results, but the estimates of the two model approach have a larger spread.
The work of Athey and Wager (2019) used a semi-synthetic dataset based on the National
Study of Learning Mindsets (NSLM) (Yeager et al., 2016) dataset. The NSLM dataset consists
of subjects from a randomized study conducted in U.S. public high schools, with the purpose to
evaluate the impact of a nudge-like intervention designed to instill students with a growth mindset on
student achievement. The research by Athey and Wager (2019) was not conducted on the original
study, but rather on a semi-synthetic data provided by the “Empirical Investigation of Methods for
Heterogeneity” workshop of the 2018 Atlantic Causal Inference Conference. The dataset contained
about 10,391 subjects from 76 schools with a simulated outcome variable, a binary treatment indicator
of the nudge-like intervention and 10 covariates describing the characteristics of the students and the
school. This dataset can be accessed at https://github.com/grf-labs/grf/tree/master/experiments/acic18.
The authors have found that the subjects’ schools contribute significantly to the treatment effect
heterogeneity. When the school induced heterogeneity is controlled (by sampling randomly for
subjects in each school instead of for all the subjects), the heterogeneity is significantly smaller.
4.3 Applications in personalized medical treatments
Personalized medical treatment is another major application of the treatment effect heterogeneity
community. However, some uplift modeling literature also considered personalized medical treat-
ments (Nassif et al., 2012b; Jaskowski and Jaroszewicz, 2012). A difference between the work from
the two communities in this area is that the works in the treatment effect heterogeneity community are
more focused on the medical implication of the results, while most works from the uplift modeling
community used the medical datasets for comparing different models.
Cai et al. (2011) studied the personalized treatment problem with the two model approach using
both regression and logistic regression. They used a dataset from a clinical trial conducted by the
AIDS Clinical Trials Group (ACTG). The trial is designed to study the effect of a protease inhibitor
for treating human immunodeficiency virus (HIV) infection (Hammer et al., 1997). A total of 1156
patients are included in the trial and are randomly divided into treated and control groups. The
control group subjects are given a 2-drug combination: zidovudine and lamivudine; while the treated
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group subjects are given a 3-drug combination consisting of the previous two drugs and indinavir.
The previous study shows that the treatment is significantly more effective than the control; however,
it was also noted that some patients do not respond to the treatment but instead suffer from toxicity
side effects. In order to identify which subgroups that do not benefit from the treatment, the authors
considered 3 covariates including CD4 count at week 0, virus RNA count at week 0, and age. The
change of CD4 count at week 24 from the baseline level is an indicator of treatment efficacy, and
is used as the continuous outcome. Regression is used for the continuous outcome. RNA count
below 500 copies per millilitre in the week 24 is used as the binary outcome as in the previous study.
Logistic regression is used for the binary outcome and 10-fold cross validation is used for evaluation.
Predicted treatment effect using training model is used to score the patients in the test data set. The
results shows that the treatment effects of highly scored and lowly scored patients were significantly
heterogeneous. The authors have found that subjects older than 40, with high virus RNA count at
week 0 and low CD4 count at week 0 significantly benefited from the treatment, while those subjects
younger than 40 with low virus RNA count at week 0 but high CD4 count at week 0 did not benefit
from the treatment.
Nassif et al. (2013) utilized uplift modeling to identify older patients who would not be benefited
from a treatment for breast cancer. Some older patients who are in the earlier in-situ stage of breast
cancer progress much slower than young patiences in the same stage, and hence should not go
through a treatment. This work built uplift models to identify older patients who are different from
young patients at situ stage based on mammography features. The dataset contains two cohorts
of breast cancer patients: younger than 50 years and older than 65 years, and the older group is
considered as the treated and the younger group as the control. Two cancer stages: earlier in-situ
and subsequent invasive are positive and negative outcomes. The data set contains: 132 positive
and 401 negative cases in the treated group and 110 positive and 264 negative cases in the control
group. They used a two model approach with a rule based classifier called SAYU (Davis et al., 2005).
The area under the uplift curve based on the 10 fold cross validation is used for evaluation. The two
model SAYL performed better than Differential Prediction Search (DPS) and Model Filtering (MF)
methods, both of which are rule based two model uplift modeling methods proposed by the same
group of authors (Nassif et al., 2012a).
Weisberg and Pontes (2015) applied CATE estimation algorithms to the clinical trial data of
the Randomized Aldactone Evaluation Study (RALES). Aldactone is a medicine for treating fluid
build-up due to heart failure, liver scarring or kidney disease, and the trial was designed to test
whether the medicine can reduce the mortality of patients who suffer from severe heart failure. With
Aldactone as the treatment, the study used 63 variables describing the demographics, history and
concomitant medications as covariates, and the maximum potassium level (continuous) within the
first 12 weeks of treatment as the outcome. The authors used a transformed outcome approach (as
discussed in Section 3.1.4) similar to Jaskowski and Jaroszewicz (2012). The model was built on
80% of the total of 1632 subjects and tested on the remaining 20% subjects. The study shows that the
treatment, although highly significant in the original study (Pitt et al., 1999), is no longer significant
when the individual characteristic of the subjects are considered.
Zhang et al. (2017) extended the Causal Tree (Athey and Imbens, 2016) algorithm (as discussed in
Section 3.2.1 ) to censored survival outcomes and used it to study the heterogeneous treatment effects
of radiotherapy on the survival outcomes of breast cancer patients and glioma cancer patients caused
by the patients’ gene profiles. The breast cancer dataset contains 964 subjects and the expression
profile of 11,535 genes, and the glioma cancer dataset contains 632 subjects and 11,543 genes. For
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each dataset, about 50% of the subjects have been treated with radiotherapy while the rest are not
treated. The datasets can be accessed from TCGA (The Cancer Genome Atlas). For both breast
cancer and glioma, they identified four subgroups of patients: two subgroups of subjects responding
positively to radiotherapy and have longer survival expectations, one subgroup of subjects responding
negatively to radiotherapy and have shorter survival expectations, and another subgroup of subjects
showing no significant responses to the treatment. The proposed method was compared with popular
cancer subtype clustering methods including semi-supervised clustering (Bair and Tibshirani, 2004)
and L1-regularized COX proportional hazard model (Goeman, 2009). Results on individual test
sets showed that the CATE estimation method is better at finding subgroups with treatment effect
heterogeneities.
Atan et al. (2018) applied the Deep-Treat deep learning based CATE estimation algorithm
(as discussed in Section 3.1.5) to the breast cancer patients participating in the National Surgical
Adjuvant Breast and Bowel Project (NSABP) (Yoon et al., 2017). The dataset consists of 10,000
patients described by their clinical features such as age, tumor related features such as tumour stage,
genetic features such as estrogen receptor, progesterone receptor, etc. Six treatments corresponding
to different chemotherapy regimes (AC, ACT, AT, CAF, CEF, CMF) are considered. The outcomes
are derived by aggregating the 5 year survival rates of the regime based on 32 references from
PuMed Clinical Queries. The authors compared the algorithm with a two model approach with
Linear Regression, a single model approach with Multilayer Perceptron using a separated training,
validation, and test splits of the dataset. The results showed that Deep-Treat performs better than the
compared algorithms.
5. Discussions based on examples
In this section we provide discussions based on empirical evaluations of the available packages and
recently proposed methods from both uplifting and CATE communities. Our aim is to summarise
available software packages and source codes, illustrate and demonstrate the methods on synthetic,
semi-synthetic and real-world data sets, and discuss their modeling behaviour, usability, interpretabil-
ity and scalability. We do not aim to find the best performing method since it is beyond the scope
of this survey. For an empirical evaluation focused on comparing the accuracies of some of the
algorithms for treatment effect heterogeneity modeling, we refer the readers to the work by Dorie et.
al. (Dorie et al., 2019). For empirical evaluations focused on comparing the performances of some of
the uplift modeling algorithms, we refer the readers to the works of Devriendt et al. (Devriendt et al.,
2018) and Gubela et al. (Gubela et al., 2019).
5.1 Software packages and source codes
We first summarise the available software packages for uplifting modeling and CATE estimation in
Table 1. Then we summarise the recently proposed methods based on deep learning for which the
authors have provided source codes but not as a software package. A summary of these new methods
with source codes is provided in Table 2.
For the software packages, we include those that are documented and are easy for end-users to
use , as described in the following. The causalTree package implements the Causal Tree (Athey
and Imbens, 2016) (as discussed in Section 3.2.1), the Squared t-statistics Tree (Su et al., 2009) (as
discussed in Section 3.2.1), and the transformed outcome approach (as discussed in Section 3.1.4)
using regression tree (RT) as base learner. The causalToolbox package which implements the single
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Table 1: Software packages for CATE estimation and uplift modeling. B, C, and N denote Binary, Categorical,
and Numerical, respectively. causalToolbox implemented the meta algorithms using RF and BART as base
learners. CausalML implemented the meta algorithms using LR, XGBoost and MLP as base learner.
Package
Covariates
B C N
Outcome
B N
Methods Language & URL
causalTree X X X X X
Causal Tree
t-stats Tree
TO# Tree
R:https://github.com/susanathey/
causalTree
causalToolbox X X X X X
Single Model
Two Model
X-Learner
TO#
R:https://github.com/soerenkuenzel/
causalToolbox
grf X × X X X Causal Forest R:https://CRAN.R-project.org/
package=grf
Uplift X X X X ×
UpliftDT
UpliftRF
UpliftCCIF
R:https://cran.r-project.org/
package=uplift
CausalML X X X X X∗
UpliftDT
UpliftRF
UpliftCCIF
Single Model
Two Model
X-Learner
Python:https://github.com/uber/
causalml
*: the uplift modeling methods in CausalML are implemented for binary outcomes only. #: TO refers to the
transformed outcome approach.
Table 2: Source codes for deep learning based CATE estimation algorithms. B, C, and N denote Binary,
Categorical, and Numerical, respectively.
Covariates
B C N
Outcome
B N
Methods Language Link
CFR X × X × X CFR Python https://github.com/
clinicalml/cfrnet
SITE X × X × X SITE Python https://github.com/
Osier-Yi/SITE
CEVAE X × X × X CEVAE Python https://github.com/
AMLab-Amsterdam/CEVAE
model approach, the two model approach, X-Learner, and transformed outcome approaches (as
discussed in Section 3.1.1, 3.1.2, 3.1.3, and 3.1.4) using Random Forest (RF) and BART as base
learners. The grf package implements the Causal Forest algorithm as discussed in Section 3.2.4.
The uplift package is developed by the uplift modeling community and provides implementation
of the Uplift Decision Trees (UpliftDT) (as discussed in 3.2.1), Uplift Random Forest (UpliftRF)
and Uplift Causal Conditional Inference Forest (UpliftCCIF) algorithms (as discussed in Section
3.2.4). The CausalML package implements the same uplift modeling methods as the uplift package,
along with the same approaches in the causalToolbox package. However, the base learners used in
CausalML are LR, XGBoost and multi-layer perceptron, which are different from those provided in
causalToolbox.
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(a) Treated
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
0
25
50
75
0 25 50 75
X1
X 2
(b) Control
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(c) Theoretical CATE
Figure 3: Disc plots of the treated subjects, control subjects, and ground truth CATEs of the synthetic dataset.
Values in covariates X1 and X2 are grouped in bins of size 5. The disc areas are proportional to the average
outcome values/CATEs in the cubes. (a) The average Y of subjects grouped in cubes for treated. (b) The
average Y of subjects grouped in cubes for control. (c) Theoretical CATEs. Note that, the areas of discs in
sub figure c are in a different scale from sub figures (a) and (b). The scale is around 7 times smaller since the
magnitude of CATEs is small. Disc plots in Figures 4 and 5 use the same scale as the Theoretical CATE plot.
Table 2 summarizes some of the recently proposed deep learning algorithms, including the
CounterFactual Regression (CFR) (Shalit et al.), Similarity preserved Individual Treatment Effect
(SITE) (Yao et al., 2018), and Causal Effect Variational Auto-Encoder (CEVAE) (Louizos et al.,
2017) as discussed in Sections 3.1.5 and 3.2.3. These methods have shown great potential in some
of the CATE estimation tasks. However, the main difference between these source codes and the
software packages is that the source codes do not provide a ready-to-use interface for users to apply
the methods to their own datasets or to perform the tasks of parameter tuning.
5.2 An illustration
Firstly, we use a synthetic dataset to provide a visual illustration for the behaviours in the CATE
estimation of some representative methods. The data set we used was first introduced to provide an
illustration of uplift modeling methods in (Radcliffe and Surry, 2011). It consists of100,000 subjects
of two covariates, a binary treatment and a continuous outcome. The data generating procedure is
described as follows: firstly, two covariates X1 and X2 are uniformly sampled from integers in the
range from 0 to 99, then the two potential outcomes are generated based on the covariates and the
treatment. The outcomes in the control group are uniformly sampled from the interval defined by
[0, x1), and the outcomes in treatment groups are uniformly sampled from the interval defined by
[0, x1) + [0, x2)/10 + 3. In other words, the ground truth of the CATE has a linear relationship
with the covariates as τ(x) = x2/20 + 3. We generate three different sets of the data with different
treatment assignment ratios. Specifically, the treatment assignments are sampled from a Bernoulli
distribution with p = 0.5, p = 0.1 and p = 0.9 for assigning a subject to the treatment, respectively.
Visualisations of the outcomes in both treated and control groups, and the ground truth CATEs are
illustrated in Figure 3.
We use disc plots for visualisation. In the disc plots, the horizontal and vertical axes represent
the covariates X1 and X2, respectively. The size of a disc is proportional to the average value of
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(a) Two Model LR.
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
0
25
50
75
0 25 50 75
X1
X 2
(b) Two Model RT.
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(c) Two Model RF.
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
0
25
50
75
0 25 50 75
X1
X 2
(d) X-Learner LR.
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(e) X-Learner RT.
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(f) X-Learner RF.
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(g) Transformed Outcome LR.
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(h) Transformed Outcome RT.
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(i) Transformed Outcome RF.
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(j) Squared t-Statistics Tree.
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(k) Causal Tree.
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(l) Causal Forest.
Figure 4: Estimated CATEs of representative methods on the balanced synthetic data set. The disc plots use
the same scale as the theoretical CATE plot as in Figure 3.
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the outcomes (Y in Fig 3 (a) and (b)) ) or CATEs for the subjects (Fig 3 (c)) binned within in the
two dimensional space with the width of 5. For example, the size of the lower left most disc in
Figure 3 (a) represents that the average treated outcomes for subjects in the space of x1 ∈ [0, 5) and
x2 ∈ [0, 5). The lower left most disc in Figure 3 (c) indicates the average CATE for subjects in that
cube. We keep the scale of the discs the same for Figure 3 (a) and Figure 3 (b), but use a different
scale for Figure 3 (c) since the average values of the CATEs are much smaller than the outcome
values. The estimated CATEs of some representative methods are shown in Figure 4 on the balanced
data set with p = 0.5. Furthermore, we also illustrate the behaviours of the selected methods (the
best from the previous illustration) on the data sets with imbalanced treatment ratio p = 0.1 and
p = 0.9 in Figure 5.
When the models are specified as same as the data generating procedure, i.e., using Linear
Regression (LR) as the base learner, the CATE modeling behaviours of the algorithms are similar
to the ground truth CATEs. This can be seen from the disc plots of Two Model LR (Figure 4 (a)),
X-Learner LR (Figure 4 (d)), and Transformed Outcome-LR (Figure 4 (g)), where the trends of
the disc plots are similar to the trends in Figure 3 (c). However, it is worth noting that in most
applications the ground truth relationships between the CATE and the covariates are unknown to the
users, and thus specifying the parametric form of the base learner is difficult.
When the models are specified differently from the data generating procedure, i.e., using Regres-
sion Tree (RT) or Random Forest (RF) as base learners, we observe that the modeling behaviours of
different methods are significantly different from each other. In the second and the third columns of
Figure 4, we can hardly see any two methods which produce the same CATE estimations. Further-
more, the two tailor-designed tree based methods, the disc plots of Squared t-Statstics Tree (Figure 4
(j)) and Causal Tree (Figure 4 (k)) are also different from each other.
Even with the same method, the performances of a method change significantly when datasets
change with different treated and control sample ratios, as shown in Figure 5. We can see that
X-Learner RF performs well when the data is balanced and when the number of the treated subjects
is smaller than the number of control subjects (p = 0.1 in Figure 5 (h)); however, its performance
significantly worsens when the treated subjects are dominant in the data (p = 0.9 in Figure 5 (i)).
An explanation of this can be seen from Equation 13. When p = 0.9 the dominating component of
the equation will be τˆ0(x) which is estimated from the control subjects and may underestimate the
treatment effects. We observe that when the weight for τˆ0(x) is reduced, X-Learner RF performs
better; however, in practice the weight can be difficult to decide for practitioners.
CATEs are difficult to model. The synthetic data set we used has only two covariates with a
sufficiently number of subjects, and the ground truth CATEs follow a linear relationship with one
covariate (X2). It is reasonable to expect that most methods should present nearly perfect estimations
of the data set. However, the results are far from perfect. When the base learner is not correct
specified, i.e. non-liner modeling methods for linear relationship in data generating procedure, the
CATE estimations change significantly when the proportion of treated samples changes as shown
in Figure 5. Even when the base learner is correct specified as the data generating procedure (Two
Model LR, X-Learner LR, and Transformed Outcome-LR), there is still a degree of under estimation
of the CATEs as the size of their discs are smaller than those in Figure 3(c).
A major reason for the difficulties of CATE estimation is the counterfactual problem where we
can only observe one of the treated/control outcomes for any subject. Another reason is that the
average values of the CATEs are weak in the data since it is only at the magnitude of around 1/20 of
an outcome value. Unfortunately, such weak signals are common in many real-world applications.
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(a) Two Model RF (balanced).
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(b) Two Model RF (p=0.1).
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(c) Two Model RF (p=0.9).
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(d) Causal Tree (balanced).
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(e) Causal Tree (p=0.1).
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(f) Causal Tree (p=0.9).
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(g) X-Learner RF (balanced).
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(h) X-Learner RF (p=0.1).
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(i) X-Learner RF (p=0.9).
Figure 5: Illustration of X-Learner Linear Regression, Transformed Outcome Linear Regression and Causal
Forest in data sets of different treatment and control sample ratios. Hollow discs indicate that the estimated
CATE is negative. The disc plots use the same scale as the theoretical CATE plot as in Figure 3.
In marketing promotion and personalised medicine applications, the scale of treatment effects is
commonly quite small. Therefore, treatment effect heterogeneity modeling and uplift modeling are
challenging and require significant amount of research work ahead.
5.3 Evaluation Metrics
Before advancing to further discussions, we formally introduce the evaluation metrics to be used.
The evaluation of conditional average treatment effect estimation methods on real-world datasets is a
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difficult task. The main reason is that there is no ground truth individual treatment effect available
for real-world datasets, because it is impossible to observe both treated and control outcomes for
the same subject. Over the years, several different evaluation metrics have been proposed from both
communities.
5.4 Metrics with known ground truth treatment effects
When the ground truth CATEs are known, i.e., synthetic datasets or semi-synthetics where the
potential outcomes are simulated based on real-world covariates, the Precision in Estimation of
Heterogeneous Effects (PEHE) (Hill, 2011) is a straightforward metric used for datasets with ground
truth individual treatment effects. Given the ground truth CATE, the PEHE is defined as
PEHE =
1
n
n∑
i
(τˆ(xi)− τ(xi))2.
In other words, PEHE measures the mean squared error between the estimated treatment effects and
the ground truth treatment effects.
Another performance metric is the mean absolute percentage error (MAPE) of the CATE estima-
tion, which can be defined as
MAPE =
1
n
n∑
i
| τˆ(xi)− τ(xi)
τ(xi)
| × 100%
5.4.1 METRICS WITHOUT GROUND TRUTH TREATMENT EFFECTS
The uplift curve and the Qini curve can be used for the evaluation of binary outcome variables
without ground truth CATE available.
The uplift and Qini curves are two closely related metrics proposed in the uplift modeling
literatures (Radcliffe, 2007; Gutierrez and Gérardy, 2017; Diemert Eustache, Betlei Artem et al.,
2018). The intuition behind these metrics is that when the subjects are ranked in the descending
order with regard to their estimated CATEs, with a more accurate CATE estimation, subjects with
positive outcomes in the treated group should be ranked higher than those with negative outcomes
within the same group (and subjects with negative outcomes in the control group should be ranked
higher than those with positive outcomes).
To define these metrics, we first introduce some additional notations. For a given CATE estimator
τˆ and subjectsxi , let pi be a descending ordering of the subjects according to their estimated treatment
effects, i.e.., τˆpi(xi) ≥ τˆpi(xj),∀i < j. In addition, we use pi(k) to denote the first k subjects from
the ordering.
Let Rpi(k) be the count of positive outcomes in pi(k), i.e., Rpi(k) =
∑
i∈pi(k) 1[Yi = 1] where
1 denotes the indicator function. Furthermore, let RT=1pi(k) and R
T=0
pi(k) be the numbers of positive
outcomes in the treatment and control groups respectively from pi(k). Finally, let NT=1pi(k) and N
T=0
pi(k)
be the numbers of subjects in the treated and control groups from pi(k). Now we can define the uplift
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curve and the Qini curve as:
uplift(k) = (
RT=1pi(k)
NT=1pi(k)
−
RT=0pi(k)
NT=0pi(k)
) · (NT=1pi(k) +NT=0pi(k) ) (29)
Qini(k) = RT=1pi(k) −RT=0pi(k)
NT=1pi(k)
NT=0pi(k)
. (30)
The uplift and Qini curves can be drawn by varying k in the above equations. It is clear to see that
the uplift and Qini curves are similar in terms of shapes (Gutierrez and Gérardy, 2017).
If we consider a random CATE estimator which predicts the outcome of the subjects using
a Bernoulli distribution with the probability of 0.5 of being either positive or negative given any
treatment, then the random baselines of uplift or Qini curves are calculated usingRT=1pi(k) = k·E[Y |T =
1] and RT=0pi(k) = k · E[Y |T = 0]. Borrowing ideas from Area Under the Curve (AUC) in standard
classification literature, the Qini coefficient (Radcliffe, 2007) of an CATE estimation algorithm is
defined as the area between the Qini curve of the algorithm and the Qini curve of a random estimator.
5.5 Demonstrations on semi-synthetic and real world data sets
In this section, we will show how the methods work using two data sets: two semi-synthetic datasets
frequently used in CATE estimation literature where the covariates are taken from a real dataset
and the outcomes are simulated such that ground truth CATEs can be calculated, and a real world
advertisement campaign dataset frequently used in the uplift modeling literature obtained from
marketing applications. Our purposes here are to show how the methods are used in real world
problems and how they are evaluated, instead of evaluating which method is the most accurate one.
Since not all methods are applied to all types of data sets, i.e., uplift modeling methods are not
applicable to data with continuous outcomes, we only apply the applicable methods to each of the
data sets.
Infant Health Development Program (IHDP) The Infant Health and Development Program
(IHDP) (Brooks-Gunn et al., 1992) dataset comes from a randomized study designed to evaluate the
effect of home visit from specialist doctors on the cognitive test scores of premature infants. The
program is a randomized controlled trial which began in 1985 and the targets of the program are
low-birth-weight, premature infants. Subjects in the treatment group are provided with intensive
high-quality child care and home visits from a trained health-care provider. The program was
effective at improving the cognitive functions of the treated subjects when compared with the control
subjects.
A version of this dataset is first used as a semi-synthetic dataset for evaluating CATE estimation
using BART by (Hill, 2011), where the outcomes are synthetically generated according to the original
covariates and selection bias is introduced by removing a non-random subset of the treated subjects
from the original randomized controlled trial dataset to create an observational dataset. Specifically,
all subjects with non-Caucasian mothers are removed. The resulting dataset contains 747 subjects
(608 control and 139 treated) with 25 covariates (6 continuous and 19 binary covariates) that describe
both the characteristics of the infants and the characteristics of their mothers. The methods for
generating the synthetic outcomes are described bellow.
We followed the same procedure as described in (Hill, 2011; Johansson et al., 2016; Louizos et al.,
2017) to replicate this semi-synthetic dataset, in which the counterfactual outcomes are simulated
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Table 3: Mean and standard errors of the PEHE and MAPE (smaller is better) across 100 replications
for training and test subjects on the IHDP datasets. Uplift Modeling methods are not reported as their
implementations are restricted to datasets with binary outcomes. T stands for the Two Model approach, TO for
Outcome Transformation approach, and X corresponds to X Learner. The first group of methods are tree based
and the last group of methods are deep learning based.
Setting A Setting B
PEHEtr PEHEte MAPEtr (%) MAPEte (%) PEHEtr PEHEte MAPEtr (%) MAPEte (%)
t-stats 1.48 ± 0.12 1.56 ± 0.13 48.3 ± 2.5 113.8 ± 25.3 6.92 ± 0.10 5.68 ± 0.09 771.3 ± 193.4 867.7 ± 127.6
CT 1.48 ± 0.12 1.56 ± 0.13 56.5 ± 4.8 148.5 ± 54.8 6.92 ± 0.10 5.70 ± 0.10 631.6 ± 81.4 841.4 ± 113.5
CF 1.01 ± 0.08 1.09 ± 0.16 34.5 ± 4.1 65.6 ± 16.9 2.77 ± 0.03 3.02 ± 0.03 331.9 ± 87.8 436.6± 103.0
T-RF 0.86 ± 0.69 0.99 ± 0.09 30.5 ± 3.4 56.5 ± 18.1 2.89 ± 0.03 3.15 ± 0.04 426.7 ± 94.5 516.3 ± 214.9
T-BART 0.60 ± 0.02 0.68 ± 0.04 19.1 ± 1.7 34.1 ± 10.7 2.30 ± 0.03 2.51 ± 0.04 302.9 ± 50.7 320.5 ± 110.8
X-RF 0.98 ± 0.08 1.09 ± 0.15 42.6 ± 5.1 109.5 ± 40.3 3.50 ± 0.04 3.59 ± 0.06 421.3 ± 92.3 516.3 ± 216.0
X-BART 0.58 ± 0.02 0.66 ± 0.04 18.7 ± 1.9 32.5 ± 9.6 2.29 ± 0.03 2.49 ± 0.04 301.2 ± 52.3 313.5 ± 114.8
TO-RF 1.01 ± 0.09 1.07 ± 0.10 32.8 ± 3.8 80.2 ± 29.0 2.93± 0.03 3.15 ± 0.05 378.5 ± 95.3 450.3 ± 98.6
TO-BART 0.86 ± 0.02 0.91± 0.04 25.0 ± 2.7 45.8 ± 16.0 2.40 ± 0.03 2.60 ± 0.04 338.2 ± 68.9 336.6 ± 138.4
CFR 0.67 ± 0.02 0.73 ± 0.04 23.4 ± 2.5 40.6 ± 13.8 2.60 ± 0.04 2.76 ± 0.04 338.2 ± 68.9 385.6 ± 161.9
SITE 0.65 ± 0.07 0.67 ± 0.06 22.3 ± 2.4 38.5 ± 11.2 2.65 ± 0.04 2.87 ± 0.05 338.2 ± 68.9 390.7 ± 168.0
CEVAE 1.13 ± 0.07 1.37 ± 0.19 46.6 ± 4.2 86.7 ± 20.8 3.06 ± 0.03 3.42 ± 0.05 400.5 ± 110.8 490.8 ± 135.8
using the Non-Parametric Causal Inference (NPCI) package (Dorie, 2016) with “Setting A” and
set “sample.kind” to “rounding” where semi-synthetic refers to the fact that the covariates are the
same as those in the original IHDP dataset; however, the outcomes are simulated so that ground
truth CATEs are available for evaluation. Furthermore, we also generate and experiment with the
data generated using the same software, but with "Setting B" option. Since the covariates are the
same as the original IHDP dataset, the difference between the two settings lies in how the outcomes
are simulated. That is, "Setting A" simulates a linear relationships between the outcome and the
covariates whereas "Setting B" simulates an exponential relationship.
For "Setting A", the treated and control potential outcomes are sampled from Y (0) ∼ N (XβA, 1)
and Y (1) ∼ N (XβA + 4, 1), where the coefficients in vector β are randomly sampled values from
(0, 1, 2, 3, 4) with probabilities of (0.5, 0.2, 0.15, 0.1, 0.05). In other words, the synthetic outcomes
are generated ensuring that the average treatment effect is 4 which is the same as the original
IHDP data. For "Setting B", the outcomes are sampled from Y (0) ∼ N (exp[(X + W )βB], 1)
and Y (1) ∼ N (XβB − ωB, 1). W is an offset matrix with the same size of X and all entries
in W equals to 0.5, ωB is selected to ensure that the average treatment effect calculated from the
generated outcomes is 4, and the coefficients in vector βB are sampled from (0, 0.1, 0.2, 0.3, 0.4)
with probabilities of (0.6, 0.1, 0.1, 0.1, 0.1). The reported performances are calculated by averaging
over 100 replications with a training/validation/test split proportion of 60%/30%/10%.
The results for the two settings of the IHDP dataset are shown in Table 3. For the deep learning
methods, parameters are grid-searched using the validation set over the suggested parameter set
recommended by the relevant papers. For all methods based on ensemble of trees (i.e., Random
Forest and BART based algorithms) the best number of trees is selected from 100 to 1000 in the
interval of 100. For methods based on a single tree model such as Causal Tree, pruning is conducted
by cross-validation implemented within the software packages.
For Setting A, we look at the relative RELs in the test data. We note that at least one method in
each group performs well and we cannot categorically say which group of methods is better than
others. Also, just based on one data set, we cannot make a generalization either. However, Two
Model based methods perform quite well on this data set. Because of the simplicity of a Two Model
method and its high flexibility for choosing a off-the-shelf modeling method. It is a good idea to try
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(a) Uplift curves on the training data.
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(b) Uplift curves on the test data.
Figure 6: Uplift Curves for the compared methods on the training and test sets of the Email Dataset. This
Figure is best viewed in colour. The black solid lines indicate the curves by random predictions.
a Two Model method as a starting point in an application. From the application view point, a half
methods produce some useful models since their relative RELs are around 50
For Setting B, we can see that the performances of the compared methods are not satisfactory
since the smallest MAPE is larger than 300%. This can be explained by the fact that the sample size
of the IHDP semi-synthetic datasets is rather small (747 samples), and thus it would be difficult for
the non-parametrically recovering of the non-linear exponential relationships between the conditional
average treatment effects and the covariates.
Hillstrom’s Email Advertisement Dataset The Hillstrom’s Email dataset (Hillstrom, 2008) con-
tains records from an email marketing campaign collected for an uplift modeling challenge. It
contains around 42,000 subjects where each subject corresponds to a customer of an online retailer.
This dataset has two treatment groups and a control group, where the first treatment is sending the
subjects an email containing "men’s advertisement", the second treatment is sending the subjects an
email containing "women’s advertisement", and the control treatment is not sending any email. The
treatment assignment is completely random. As a result, a third of the subjects receives the men’s
treatment, the women’s treatment and the control treatment, respectively. There are 7 pre-treatment
variables in the dataset, describing the biological, geological and the purchase history of the cus-
tomers. The dataset contains two outcome variables, the first one is the "visit’ status describing
whether the customer has visited the store and the second one is the "purchase" status describing
whether the customer has made any purchase. For our illustrative purpose, we use the "men’s adver-
tisement" as treatment and the "visit" variable as outcome (the algorithms show similar performances
when using the "women’s advertisement" as treatment). On average, the "men’s advertisement"
treatment increase the "visit" outcome by 7.6%. We run the algorithms using a 70%/30% split of
training and test sets without repeats.
For the parameters of neural network methods, we use grid search to search for an optimal
parameter set that achieves the minimum loss on the validation dataset which consists of 30% of the
whole dataset, and then train the network using the selected parameters on the entire set. For CFR,
the parameters we grid searched include the combination of the following: number of representa-
tion layers: {3, 4, 5}, number of regression layers: {3, 4, 5}, pre-representation layer dimensions:
{100, 200, 300, 400, 500}, post-representation layer dimensions: {100, 200, 300, 400, 500}, imbal-
ance regularization parameters: {0, 0.001, 0.01, 0.1, 0.316, 1, 3.16, 10}, consisting a grid of 1800
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(a) Qini curves on the training data.
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(b) Qini curves on the test data.
Figure 7: Qini curves for the compared methods on the training and test sets of the Hillstrom email Dataset.
These figures are best viewed in colour. The black solid lines indicate the curves by random predictions.
parameter combinations. For CEVAE, we grid searched number of hidden layers {3, 4, 5}, num-
ber of hidden layer dimensions: {100, 200, 300, 400, 500}, number of latent factor dimensions:
{5, 10, 15, 20, 25, 30}, and learning rates {0.0001, 0.005, 0.001, 0.05, 0.01}, consisting a grid of 450
parameter combinations. For other methods, we use the default parameter setting suggested by the
software package. Note that the source codes for CF, CFR, and CEVAE are not designed to handle
categorical covariates. We tried transforming the categorical covariates into binary ones using one
hot encoding; however, the results are poor and thus we do not include them here.
The uplift curves and the Qini curves on the Hillstrom email dataset are illustrated in Figure 6
and Figure 7, respectively. Firstly, we see that the majority of models do predict uplifts in the test
data set, but the achieved improvements over the baseline model is smaller in comparison to the
improvements obtained in the training data set. We also note that the rankings of the methods between
the training dataset and the test dataset are also inconsistent. These results indicate a difficulty in
evaluating the performances of uplift modeling when the ground truth is unknown (which is common
in practice). Cross validation is often used in evaluating a uplift model, but it is an open question
whether cross validation is a valid means since the uplifts are unobserved in the test data sets. In
contrast, for evaluating a supervised method, the outcomes are observed the test data set. Secondly,
we can see the trends in the uplift curves and the Qini curves have slight differences although they
are largely consistent. For example, X-RF is better than Uplift-RF in the uplift curves, but is worse
than Uplift-RF in the Qini curves.
5.6 Scalability
As datasets get larger, it becomes imperative to understand how the CATE estimation and uplift
modeling methods scale. We compare the running times of different algorithms with varying number
of subjects and covariates. The comparison is done using a PC with a AMD Ryzen 3700x processor
and 32GB of RAM. For deep learning based methods, the running times are obtained using a single
Nvidia GeForce GTX 1080 Ti graphic accelerator with 11GB of RAM. For GPU training, the batch
sizes are set to one fifth of the number of subjects, and a total of 200 epochs of training is performed.
Each experiment has been repeated for 10 times and the average running time is reported.
In order to study the time complexity of uplift modeling and CATE estimation methods, we utilize
a synthetic dataset proposed in (Häggström, 2017). In this dataset, the causal structure between the
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Figure 2
A causal DAG with unobservables.
all of the criteria would in this setting select the same sets as in the previous setting. However, the set selected
by the common cause criterion, {X1, X2, X7} 6= Q→T , would not result in unconfoundedness since it does not
include the covariate X4, which is now related to both T and Y , the latter through the unobserved variable
U3. The set selected by the pretreatment criterion would fail to achieve unconfoundedness due to the inclusion
of the covariate X9, which is now a collider on the path between T and Y due to the unobserved variables U1
and U2. Conditioning on X9 will thus open up this path between T and Y and introduce the so called M -bias
(Greenland, 2003). The sets selected by the backdoor path criterion and the disjunctive cause criterion would
however achieve unconfoundedness since both sets would include X4 but not X9. The disjunctive cause criterion
with backward selection would select S = {X1, X2, X4, X5, X6, X7, X8} = W→Y which includes X4 since it is
now associated with the outcome and conditioning on this set upholds unconfoundedness. Conditioning on
Q→T would also, in this case, result in unconfoundedness.
Note that here the sets defined in de Luna et al. (2011) are XT = X→T ∪ {X9}, XY = X→Y ∪ {X4, X9},
Q = Q→T ∪ {X9} and Z = Z→Y ∪ {X4, X9}, all including X9.
4 Covariate Selection When the Causal Structure is Unknown
Given the setup stated in Section 2, and no further knowledge on the causal structure, only the pretreatment
criterion can be readily used without aid of data-driven procedures. If we, in some way, from data estimate the
dependence structure in the form of an undirected or directed graph then we can use the estimated graph to
select covariates by reading off which covariates are related to T and/or Y | T = t for t = 0, 1.
There are many different methods available for estimating Markov and Bayesian networks (see, e.g., Fried-
man et al., 1999; Spirtes et al., 2000; Chickering, 2002; Tsamardinos et al., 2006, and references therein). In
this paper, the Max-Min Parents and Children Algorithm (MMPC) and the Max-Min Hill-Climbing Algorithm
(MMHC) are used to estimate the underlying structure of the data. Algorithms used for estimating such net-
works can be classified as either constraint-based or score-based. MMHC is a hybrid algorithm which as a first
step uses the constraint-based MMPC algorithm to estimate a Markov network, i.e., an undirected graph, and
4
Figure 8: Causal structure used for generating the data used for evaluating the scalability (Häggström, 2017).
10 covariates, the treatment T , and the outcome Y is depicted in Figure 8. To evaluate the scalability
with regard to the number of variables, additional variables (which are not related to the treatment or
the outcome) are randomly sampled from Gaussian distributions and added to the covariates. As a
result, the number of variables varies from 10 to 1,000 with the number of subjects fixed at 10,000.
For evaluating scalability with regard to the number of subjects, we fix the number of variables at
100, and vary the number of subjects from 1,000 to 50,000. Multiple CPU parallelization is not used
for the ensemble-based algorithms. In other words, the time performance of all reported results are
achieved with a single CPU and a single GPU. For ensemble methods using BART and Random
Forest as base learners, their time efficiency can be improved by utilizing multiple CPUs.
Number of subjects The running time comparison for different numbers of subjects is shown
in Figure 9. Not surprisingly, the two tree based methods: Causal Tree (CT) and t-statistics tree
(t-stats) are the fastest among all the compared algorithms. The representative neural network based
algorithms, CEVAE and CFR use almost consta t time regardless the number of subjects. This
means that they are efficient when the number of subject is large. The slowest running methods are
those bas d on BART, including X-BART, T-BART, and TO-BART, which would be slow even if
multi-core parallelization is used. For methods based on random forests, i.e., Causal Forest (CF),
X-RF, T-RF, and TO-RF, they are faster than the neural network algorithms when sample sizes are
small, but become slower as the numbers of subjects continue to increase.
Number of Covariates The running time comparison for different number of covariates is shown
in Figure 10. Similar to the number of subjects results, the two tree based methods, CT and t-stats
are the fastest. Neural network based algorithms, CEVAE and CFR also use alm st c stant times
regardless the number of variables. They can handle data sets with a large number of variables
very well. The slowest running methods are those based on Random Forests, including X-RF, T-RF,
TO-RF, and UpliftRF. The running times of BART based algorithms are similar, and they are faster
than RF based algorithms but slower than deep learning based algorithms.
5.7 Discussions
The usability, interpretability and scalability of the methods are listed in Table 4. Usability is about
the ase of use of a software and of its para eter setting a tuning requirement. Interpr tability
refers to the level of explanations provided for a prediction, for example, whether a predicted outcome
linked to some specific covariate values as reasons. Scalability is about the speed of a method in
relation to the data ize and umber of covariates.
36
SURVEY OF TREATMENT EFFECT HETEROGENEITY AND UPLIFT MODELING
0.0
2.5
5.0
7.5
0 10000 20000 30000 40000 50000
Number of Samples
lo
g 
tim
e 
(s)
CEVAE
CF
CFR
CT
T−BART
T−RF
t−stats
TO−BART
TO−RF
UpliftCCIF
UpliftRF
X−BART
X−RF
Figure 9: Time complexity of the compared methods by varying the number of subjects (best viewed in color).
The curves for CFR and SITE are similar, therefore we only show the curve of CFR to avoid cluttering.
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Figure 10: Time complexity of the compared methods by changing the dimensionality (best viewed in color).
The curves for CFR and SITE are similar, therefore we only show the curve of CFR to avoid cluttering.
Based on our experience with various uplift modeling and treatment effect heterogeneity modeling
methods, we have the following observations.
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Table 4: Summarisation of the usability, interpretability and scalability of the uplift modeling and CATE
estimation packages and algorithms.
Methods Usability Interpretability Scalability
Single Model Depending on the
base method; can be
very easy to use.
Treatment effect needs
to be derived; Result
can be interpretable.
Scalability to the #covariates
and #subjects can be very
good.
Two Model
X-Learner
Outcome Transform
Causal Tree Easy to use with few
parameters to set.
Treatment effect is
directly given. Result
is interpretable.
Scalability to the
#covariates* and #subjects is
very good.
t-stats Tree
Uplift Tree
Causal RF Easy to use with few
parameters to set.
Treatment effect is
directly given; Result
is not interpretable.
The time for building a base
learner can be long, but the
scalability to #covariates and
#subjects is good.Uplift RF
CFR The networkstructure and
parameters are
difficult to set.
Treatment effect is
directly given; Result
is not interpretable.
The base learning process is
long, but the training time is
not affected by #covariates
much. Methods are scalable
to #subjects.
CEVAE
∗When using propensity score matching, the scalability with #covariates is not good.
• The accuracy of a method is data set specific. For example, X-Learner BART performs very
well in the IHDP data set, but performs just marginally better than the baseline in Hillstrom’s
Email dataset. There is not good understanding which method suits which type of data in
literature.
• The accuracy of ensemble methods is stable over the data sets, although they may not be the
best all the time. This is expected, as discussed in (Sołtys et al., 2015) where the authors
observed that ensemble methods frequently outperform methods that build a single model.
However, ensemble methods suffer from lack of the interpretability and their training time is
usually long.
• The accuracy of the single model approach is usually low. The accuracies for the two model
approaches and X-Learner methods are competitive. Based on their design, the two model
approaches are good for data set with balanced treatment and control subjects, and X-Learner
methods are good for unbalanced data. One major strength of both X-Learner and the two
model approach is that they provide good flexibility for using a rich set existing supervised
methods.
• The performance of deep learning based methods is determined by dedicated parameter tuning
for each specific dataset. Neural networks are known prone to data variability and parameter
selection (Novak et al., 2018). This is more problematic in treatment effect estimation than in
supervised learning, since there are no ground truth treatment effects in most cases.
The limitations of this survey are listed as the following. Firstly, we focus our discussion
on a single binary treatment and exclude the discussion of non-binary treatment (e.g., ordinal or
continuous treatments) and multiple treatments. We focus on a single treatment since almost all
of the surveyed methods can be extended to the case of multiple treatments, following a similar
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means as extending binary classification algorithms to multi-class classification. However, there are
some methods specifically designed for handling multiple treatments. We refer the readers to Olaya,
Coussement and Verbeke (Olaya et al., 2020) for a recent survey on uplift modeling with multiple
treatments. Secondly, we exclude the discussion of non-binary treatment since most of the existing
methods are designed for binary treatment. Recently, several methods for non-binary treatments have
been proposed from the treatment effect heterogeneity modeling community, and we refer readers to
the work of Zhao, Dyk and Imai (Zhao et al., 2020) for an overview of these methods.
6. Conclusions
Estimating the heterogeneous effects of an action on the outcomes of individual subjects is an
important problem in a wide range of applications. Motivated by different application scenarios,
researchers from the treatment effect heterogeneity modeling and the uplift modeling communities
have simultaneously contributed to the solving problem in the last decade.
In this article, we have provided a unified survey for the methods proposed by the treatment
effect heterogeneity modeling and the uplift modeling communities. Using the potential outcome
framework, we have shown that, with the overlap, STUVA, and unconfoundedness assumptions,
the objectives of treatment effect heterogeneity modelling and uplift modelling are the same, and
they both estimate the Conditional Average Treatment Effect (CATE) in data. With the unified
objective and notations, we have structurally reviewed methods in both communities and focused on
the inherent connections between methods. Most methods are strongly linked to supervised machine
learning methods, but we should stress here that CATE estimation is not a supervised learning
problem and understanding the assumptions is crucial to ensure the correct use of the methods. We
have discussed the applications of the methods in targeted marketing, personalized medicine and
social studies. Finally, we have summarized existing open-source software packages and some source
codes and demonstrate them in synthetic, semi-synthetic and real-world datasets. We show that
CATE estimation and evaluation are challenging tasks, and provide some general guidelines for
choosing methods based on our experience with the methods.
An important direction of future work is to find a way to strike balance between the interpretability,
the ease of use, and the accuracy of the method. On the one hand, deep learning methods are accurate
in CATE estimation when their network structure and parameters are carefully tuned for the problem;
however, their parameter and structure tuning procedure is difficult for practitioners and they generally
lack interpretability. On the other hand, tree based methods are easy to interpret and require minimal
parameter tuning, but their performances are often not the best.
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